[go: up one dir, main page]

CN110859994B - A kind of modified tussah silk fibroin 3D printing scaffold and preparation method thereof - Google Patents

A kind of modified tussah silk fibroin 3D printing scaffold and preparation method thereof Download PDF

Info

Publication number
CN110859994B
CN110859994B CN201910773760.9A CN201910773760A CN110859994B CN 110859994 B CN110859994 B CN 110859994B CN 201910773760 A CN201910773760 A CN 201910773760A CN 110859994 B CN110859994 B CN 110859994B
Authority
CN
China
Prior art keywords
silk fibroin
tussah silk
printing
modified
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910773760.9A
Other languages
Chinese (zh)
Other versions
CN110859994A (en
Inventor
邵惠丽
邹盛之
张耀鹏
王心如
张佳明
范苏娜
胡学超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Donghua University
Original Assignee
Donghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donghua University filed Critical Donghua University
Priority to CN201910773760.9A priority Critical patent/CN110859994B/en
Publication of CN110859994A publication Critical patent/CN110859994A/en
Application granted granted Critical
Publication of CN110859994B publication Critical patent/CN110859994B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222Gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y10/00Processes of additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00Materials specially adapted for additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00Products made by additive manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明涉及一种改性柞蚕丝素蛋白3D打印支架及其制备方法,采用经化学修饰的柞蚕丝素蛋白纳米微纤维制得的核部分打印墨水和经化学修饰的柞蚕丝素蛋白纳米微纤维/明胶复合体系制得的壳部分打印墨水进行3D打印制备改性柞蚕丝素蛋白3D打印支架;其中,改性柞蚕丝素蛋白3D打印支架经质量浓度为0.1~5wt%的京尼平浸泡交联反应24h后的压缩模量为100~600MPa,培养10天后诱导多能干细胞的存活率和增殖率较高;最终制得的改性柞蚕丝素蛋白3D打印支架,由具有核壳结构的打印线条构成。本发明的制备方法相对简单,制备得到的3D打印支架具有优异的力学性能、优良的生物相容性以及良好的组织修复能力。The invention relates to a modified tussah silk fibroin 3D printing scaffold and a preparation method thereof. The core part printing ink and the chemically modified tussah silk fibroin nano-microfibers are prepared by using chemically modified tussah silk fibroin nano-microfibers. The modified tussah silk fibroin 3D printing scaffold was prepared by 3D printing with the shell part printing ink prepared by the composite system of gelatin/gelatin; wherein, the modified tussah silk fibroin 3D printing scaffold was soaked in genipin with a mass concentration of 0.1-5 wt%. The compressive modulus after the combined reaction for 24 hours was 100-600 MPa, and the survival rate and proliferation rate of induced pluripotent stem cells were high after 10 days of culture. line composition. The preparation method of the present invention is relatively simple, and the prepared 3D printed scaffold has excellent mechanical properties, excellent biocompatibility and good tissue repair ability.

Description

一种改性柞蚕丝素蛋白3D打印支架及其制备方法A kind of modified tussah silk fibroin 3D printing scaffold and preparation method thereof

技术领域technical field

本发明属于生物3D打印技术领域,涉及一种改性柞蚕丝素蛋白3D打印支架及其制备方法。The invention belongs to the technical field of biological 3D printing, and relates to a modified tussah silk fibroin 3D printing support and a preparation method thereof.

背景技术Background technique

创伤、肿瘤以及老龄化等原因造成的组织、器官缺损和功能障碍是危害人类健康的重要因素,而缺损组织、器官的修复和功能重建是目前国际面临的难题。大面积的缺损通常都需要采用自体或异体组织、器官移植进行修复,自体移植存在着“以创伤修复创伤”的问题,而对于异体移植治疗,也存在着供体来源不足、免疫排斥等主要缺点。组织工程学(tissue engineering)的提出、建立和发展,为解决该类组织、器官缺损和功能障碍的难题提供了新的途径。从上世纪80年代初提出将细胞植入可降解生物材料上以构建组织的设想,到近年来应用组织工程技术修复临床缺损的成功,组织工程技术已被证实是解决组织创伤修复、功能重建的有效途径之一。Tissue and organ defects and dysfunctions caused by trauma, tumors, and aging are important factors that endanger human health, and the repair and functional reconstruction of defective tissues and organs is currently a difficult problem facing the world. Large-scale defects usually need to be repaired by autologous or allogeneic tissue and organ transplantation. Autologous transplantation has the problem of "repairing wounds with wounds", and for allogeneic transplantation, there are also major shortcomings such as insufficient donor source and immune rejection. . The proposal, establishment and development of tissue engineering provides a new way to solve the problems of such tissue and organ defects and dysfunctions. From the idea of implanting cells into degradable biomaterials to construct tissues in the early 1980s, to the success of applying tissue engineering technology to repair clinical defects in recent years, tissue engineering technology has been proved to be the solution to tissue wound repair and functional reconstruction. one of the effective ways.

近年来,生物三维(3D)打印技术的兴起在人体组织或器官的再生重建方面备受关注。生物3D打印技术是通过CAD技术模拟人体不同的组织器官并由计算机控制以生物材料、种子细胞及其他一些生物试剂为墨水来打印进行人体组织和器官重建。通过生物3D打印出的支架结构不仅具有准确性、特异性,而且能够维持细胞活力,从而满足人体各类复杂组织器官的重建需求,所以,生物3D打印必将引起生物医学领域的技术革命。然而,生物3D打印技术面临的主要挑战之一在于所用生物墨水的选择。传统的用于3D打印的材料主要是一些合成高聚物如聚乙二醇PEG、聚己内酯PCL、聚乙醇酸PGA、聚乙烯醇PVA、聚乳酸PLA等,这一类材料具有易于成型、分辨率高的优点,但也存在加工温度较高、细胞相容性差的不足,且使用这些材料所制备的支架在制备过程中一般会引入一些有毒的物质,若不能很好地将这些有毒的物质除去,则会对支架的生物相容性造成负面影响。In recent years, the rise of biological three-dimensional (3D) printing technology has attracted much attention in the regenerative reconstruction of human tissues or organs. Biological 3D printing technology simulates different tissues and organs of the human body through CAD technology and uses biological materials, seed cells and some other biological reagents as inks to print and reconstruct human tissues and organs under computer control. The scaffold structure produced by 3D bioprinting is not only accurate and specific, but also can maintain cell viability, so as to meet the reconstruction needs of various complex tissues and organs in the human body. Therefore, 3D bioprinting will definitely lead to a technological revolution in the field of biomedicine. However, one of the main challenges facing 3D bioprinting technology lies in the selection of the bioink used. The traditional materials used for 3D printing are mainly synthetic polymers such as polyethylene glycol PEG, polycaprolactone PCL, polyglycolic acid PGA, polyvinyl alcohol PVA, polylactic acid PLA, etc. These materials are easy to form. , the advantages of high resolution, but there are also the shortcomings of high processing temperature and poor cell compatibility, and the scaffolds prepared by using these materials will generally introduce some toxic substances during the preparation process. The removal of these substances will negatively affect the biocompatibility of the stent.

相比于以上合成材料,丝素蛋白是一种具有较好生物相容性的天然高分子材料,目前已有许多人对其在生物材料中的应用展开了研究,也有人将其运用于3D打印领域,制备出了生物支架材料。Compared with the above synthetic materials, silk fibroin is a natural polymer material with better biocompatibility. At present, many people have carried out research on its application in biological materials, and some people have applied it to 3D. In the field of printing, biological scaffold materials have been prepared.

专利CN108085760A公开了一种纸团状石墨烯改性的光固化蚕丝蛋白三维打印材料及其制备方法,其中包含用于3D打印的墨水,所述墨水包括氧化石墨烯溶液和家蚕丝素蛋白溶液;专利CN107744601A公开了一种基于蚕丝微球生物墨水的三维打印伤口包覆材料及其制备方法,其中包含用于3D打印的墨水,所述墨水包括家蚕蚕丝蛋白溶液和阿司匹林;专利CN105031728A公开了一种低温快速成型三维打印胶原丝素蛋白材料,其中包含用于3D打印的丝素蛋白墨水,所述墨水包括家蚕丝素蛋白、胶原蛋白、甘油和相容剂;专利CN105903071A公开了一种角膜支架材料及其制备方法和角膜支架的3D打印方法,其中包含用于3D打印的丝素蛋白墨水,所述墨水包括家蚕丝素蛋白、胶原蛋白、氧化石墨烯和交联剂;专利CN104958785A公开了一种具有二级三维结构的复合骨修复材料及其制备方法,其中包含用于3D打印的丝素蛋白墨水,所述墨水包括家蚕丝素蛋白、羟基磷灰石和胶原蛋白,使用该专利所述方法制出的3D组织工程支架弹性模量在290~430kPa范围内。Patent CN108085760A discloses a paper mass graphene-modified light-cured silk fibroin three-dimensional printing material and a preparation method thereof, including ink for 3D printing, and the ink includes a graphene oxide solution and a silk fibroin solution; Patent CN107744601A discloses a three-dimensional printing wound wrapping material based on silk microsphere bio-ink and its preparation method, including ink for 3D printing, the ink includes silkworm silk protein solution and aspirin; patent CN105031728A discloses a Low temperature rapid prototyping three-dimensional printing collagen silk fibroin material, which contains silk fibroin ink for 3D printing, the ink includes silk fibroin, collagen, glycerol and compatibilizer; Patent CN105903071A discloses a corneal scaffold material and its preparation method and 3D printing method of corneal stent, including silk fibroin ink for 3D printing, said ink comprising silk fibroin, collagen, graphene oxide and cross-linking agent; patent CN104958785A discloses a Composite bone repair material with secondary three-dimensional structure and preparation method thereof, including silk fibroin ink for 3D printing, said ink comprising Bombyx mori silk fibroin, hydroxyapatite and collagen, using the method described in this patent The elastic modulus of the fabricated 3D tissue engineering scaffolds is in the range of 290-430 kPa.

文献“3D printing of silk particle-reinforced chitosan hydrogelstructures and their properties”中使用了家蚕丝素蛋白(BSF)、壳聚糖和水制成的复合生物3D打印墨水进行打印,得到的支架压缩模量最大可达到5KPa;文献“Structurallyand functionally optimized silk-fibroin–gelatin scaffold using 3D printing torepair cartilage injury in vitro and in vivo”使用了家蚕丝素蛋白(BSF)、明胶和水制成的复合生物3D打印墨水进行打印,得到的支架弹性模量最大可达到15kPa;文献“Precisely printable and biocompatible silk fibroin bioink for digital lightprocessing 3D printing”使用了经甲基丙烯酸缩水甘油酯修饰的家蚕丝素蛋白(BSF)生物3D打印墨水进行打印,得到的支架弹性模量最大可达到120KPa。In the document "3D printing of silk particle-reinforced chitosan hydrogelstructures and their properties", a composite bioprinting ink made of Bombyx mori silk fibroin (BSF), chitosan and water was used for printing, and the obtained scaffolds had the highest compressive modulus. Reach 5KPa; the document "Structurally and functionally optimized silk-fibroin–gelatin scaffold using 3D printing torepair cartilage injury in vitro and in vivo" used a composite bio-3D printing ink made of Bombyx mori silk fibroin (BSF), gelatin and water for printing, The elastic modulus of the obtained scaffold can reach a maximum of 15kPa; the document "Precisely printable and biocompatible silk fibroin bioink for digital lightprocessing 3D printing" uses glycidyl methacrylate modified Bombyx mori silk fibroin (BSF) bioprinting ink for printing , the elastic modulus of the obtained stent can reach a maximum of 120KPa.

以上几项研究将3D打印技术均运用到了丝素蛋白领域,但上述研究均只研究了家蚕丝素蛋白的3D打印。而中国特有的柞蚕丝素蛋白分子链中具有家蚕丝素蛋白分子链中所不具有的由精氨酸、甘氨酸、天冬氨酸首尾相连而成的RGD三肽链段,该链段已被证明具有较高的细胞粘附性,所以相比于家蚕丝素蛋白,柞蚕丝素蛋白有望具有更佳的生物相容性。此外,柞蚕丝素蛋白分子链中含有大量丙氨酸链段(AAAAAAAAA…),其相比于家蚕丝素蛋白中所大量含有的甘氨酸-丙氨酸-丝氨酸交替链段(GAGAGASGAGAGAS…)具有更高的规整性,可以赋予打印支架更优异的力学性能。因此,相比于家蚕丝素蛋白,柞蚕丝素蛋白在3D打印领域中的应用更具潜力。The above studies have all applied 3D printing technology to the field of silk fibroin, but the above studies only studied the 3D printing of silk fibroin. The unique Chinese tussah silk fibroin molecular chain has an RGD tripeptide chain segment composed of arginine, glycine, and aspartic acid, which is not found in the silk fibroin molecular chain of Bombyx mori. It is proved to have higher cell adhesion, so compared with Bombyx mori silk fibroin, tussah silk fibroin is expected to have better biocompatibility. In addition, the molecular chain of tussah silk fibroin contains a large number of alanine segments (AAAAAAAAA...), which has more glycine-alanine-serine alternating segments (GAGAGASGAGAGAS...) High regularity can endow the printed scaffold with better mechanical properties. Therefore, compared with Bombyx mori silk fibroin, tussah silk fibroin has more potential in the field of 3D printing.

为此,专利CN106267370A公开了丝素蛋白/纤维素3D打印墨水,所述墨水包括水溶性丝素蛋白、非水溶性纤维素微/纳米材料、无毒性多元醇和水,使用该墨水打印出的3D支架压缩模量在10~50MPa范围内。该专利所公开的内容中包含了基于柞蚕丝素蛋白水溶液的3D打印墨水的相关内容,但相关研究人员发现,柞蚕丝素蛋白更易在分子链间氢键作用下形成反向平行锯齿状结构,对温度、外力作用也更为敏感,柞蚕丝素蛋白溶液极容易在温度、外力作用影响下发生构象转变,形成不溶于水的固体,从而影响整个制备过程。To this end, patent CN106267370A discloses silk fibroin/cellulose 3D printing ink, the ink includes water-soluble silk fibroin, water-insoluble cellulose micro/nano material, non-toxic polyol and water. The compressive modulus of the stent is in the range of 10 to 50 MPa. The content disclosed in the patent includes the related content of 3D printing ink based on tussah silk fibroin aqueous solution, but related researchers found that tussah silk fibroin is more likely to form an anti-parallel zigzag structure under the action of intermolecular hydrogen bonds. It is also more sensitive to temperature and external force. The tussah silk fibroin solution is very easy to undergo conformational transformation under the influence of temperature and external force to form a water-insoluble solid, thereby affecting the entire preparation process.

不仅如此,柞蚕丝素蛋白分子链中大量的丙氨酸疏水链段(AAAAAAAAA…),还会使打印得到的支架具有较低的亲水性,从而对其生物相容性造成不良影响。Not only that, the large amount of alanine hydrophobic segments (AAAAAAAAA...) in the tussah silk fibroin molecular chain will also make the printed scaffolds have low hydrophilicity, which will adversely affect its biocompatibility.

为解决上述打印得到的支架的亲水性低的问题,设想若是可以对柞蚕丝素蛋白分子链进行一定的化学改性,在分子链上引入一定的亲水基团,则有望改善材料的生物相容性。In order to solve the problem of low hydrophilicity of the above-mentioned printed scaffolds, it is envisaged that if the molecular chain of tussah silk fibroin can be chemically modified and a certain hydrophilic group is introduced into the molecular chain, it is expected to improve the biological properties of the material. compatibility.

此外,若一支架具有较优异的组织修复能力,则其必须对细胞尤其是干细胞具有较为优良的粘附和增殖能力,而目前在可用于组织工程尤其是心脏组织工程的诸多种干细胞中,效果最佳的为诱导多能干细胞(iPSCs)。目前已有许多人将该细胞用于3D打印领域,制出了具有组织修复能力的3D支架。In addition, if a scaffold has excellent tissue repair ability, it must have relatively good adhesion and proliferation ability to cells, especially stem cells. At present, among many kinds of stem cells that can be used for tissue engineering, especially cardiac tissue engineering, the effect is The best are induced pluripotent stem cells (iPSCs). At present, many people have used the cells in the field of 3D printing to produce 3D scaffolds with tissue repair capabilities.

文献“3D Bioprinting Human Induced Pluripotent Stem Cell-DerivedNeural Tissues Using a Novel Lab-on-a-Printer Technology”将iPSCs装载于由纤维原蛋白、海藻酸钠、京尼平溶于水制成的生物复合3D打印墨水中进行了打印,打印后第7天iPSCs的存活率最大可以达到95%左右;文献“3D printing human induced pluripotentstem cells with novel hydroxypropyl chitin bioink:scalable expansion anduniform aggregation”将iPSCs装载在基于羟丙基甲壳素的生物3D打印墨水中进行了3D打印,发现在打印后一天内iPSCs的存活率最大可以达到95%左右,打印后10天内iPSCs的存活率均能达到90%左右,细胞增殖率为3000%~4000%;文献“Laser bioprinting ofhuman induced pluripotent stem cells—the effect of printing and biomaterialson cell survival,pluripotency,and differentiation”将iPSCs装载于不同的培养基中进行了3D打印,发现在打印后3h内iPSCs的存活率最大可以达到90%左右,打印后4天细胞增殖率可达到429%左右;文献“A simple and efficient feeder-free culture systemto up-scale iPSCs on polymeric material surface for use in 3D bioprinting”制出了基于壳聚糖、家蚕丝素蛋白和聚氨酯的多种生物3D打印墨水,并以这些墨水为基底培养了iPSCs,结果发现,培养3天后iPSCs的增殖率最大可达300%左右。The paper "3D Bioprinting Human Induced Pluripotent Stem Cell-DerivedNeural Tissues Using a Novel Lab-on-a-Printer Technology" loaded iPSCs into 3D printed biocomposites made of fibronectin, sodium alginate, and genipin dissolved in water The iPSCs were printed in the ink, and the survival rate of iPSCs could reach about 95% on the 7th day after printing. 3D printing was carried out in the bio 3D printing ink of 100% cellulose, and it was found that the survival rate of iPSCs could reach about 95% within one day after printing, and the survival rate of iPSCs could reach about 90% within 10 days after printing, and the cell proliferation rate was 3000%. ~4000%; the document "Laser bioprinting of human induced pluripotent stem cells—the effect of printing and biomaterialson cell survival, pluripotency, and differentiation" loaded iPSCs in different media for 3D printing, and found that iPSCs were 3D within 3 h after printing. The maximum survival rate can reach about 90%, and the cell proliferation rate can reach about 429% 4 days after printing; the document "A simple and efficient feeder-free culture system to up-scale iPSCs on polymeric material surface for use in 3D bioprinting" produced A variety of bio-3D printing inks based on chitosan, silk fibroin and polyurethane were used, and iPSCs were cultured with these inks as substrates. It was found that the proliferation rate of iPSCs reached a maximum of about 300% after 3 days of culture.

上述几项研究均将iPSCs运用于了3D打印领域,但没有研究3D打印支架的力学性能,对于某些需要较为剧烈机械运动的组织(如心脏)来说,支架的力学性能显得尤为重要。且针对于不同的组织部位及不同程度的组织损伤,组织工程支架材料需具备与之匹配的修复速度,而目前的生物材料3D打印支架的制备方法很难同时兼顾支架对受伤组织的修复速度及支架的其他性能。The above studies all applied iPSCs to the field of 3D printing, but did not study the mechanical properties of 3D printed scaffolds. For some tissues (such as the heart) that require relatively vigorous mechanical movements, the mechanical properties of scaffolds are particularly important. And for different tissue parts and different degrees of tissue damage, tissue engineering scaffold materials need to have a matching repair speed, and the current preparation method of biomaterial 3D printing scaffolds is difficult to take into account the repair speed and speed of the injured tissue. Other properties of the bracket.

基于以上背景,研究一种能够同时兼顾支架对受伤组织的修复速度和支架的力学性能、生物相容性以及对细胞的粘附和增殖能力并具有可控细胞生长、增殖速度功能的改性柞蚕丝素蛋白3D打印支架及其制备方法具有十分重要的意义。若能将经化学修饰的柞蚕丝素蛋白制成纳米纤维,则在墨水的制备过程中构象可以保持稳定,使制备过程更加易于操控,且支架的力学性能、生物相容性和组织修复能力可以通过调节柞蚕丝素蛋白纳米纤维的含量以及制备工艺进行调节,有望得到力学性能及组织修复能力较为优异的组织工程支架。Based on the above background, a modified tussah silkworm that can simultaneously take into account the repair speed of the scaffold to the injured tissue and the mechanical properties, biocompatibility, and cell adhesion and proliferation ability of the scaffold and has the function of controllable cell growth and proliferation speed. Silk fibroin 3D printed scaffolds and their preparation methods are of great significance. If the chemically modified tussah silk fibroin can be made into nanofibers, the conformation can be kept stable during the ink preparation process, making the preparation process easier to control, and the mechanical properties, biocompatibility and tissue repair ability of the scaffold can be improved By adjusting the content of tussah silk fibroin nanofibers and the preparation process, it is expected to obtain tissue engineering scaffolds with excellent mechanical properties and tissue repair ability.

发明内容SUMMARY OF THE INVENTION

本发明的目的是为了克服现有技术中存在的无法同时兼顾支架的力学性能和生物相容性以及对细胞的粘附和增殖能力的缺陷,提供一种改性柞蚕丝素蛋白3D打印支架及其制备方法。使用该方法制出的支架不仅具有优异的的力学性能以及对细胞的粘附和增殖能力,而且具有良好的生物相容性。此外还具有可控细胞生长、增殖速度功能。The purpose of the present invention is to provide a modified tussah silk fibroin 3D printing scaffold and the its preparation method. The scaffolds produced by this method not only have excellent mechanical properties and cell adhesion and proliferation ability, but also have good biocompatibility. In addition, it also has the function of controllable cell growth and proliferation rate.

为达到上述目的,本发明的技术方案为:For achieving the above object, the technical scheme of the present invention is:

一种改性柞蚕丝素蛋白3D打印支架的制备方法,由经化学修饰的柞蚕丝素蛋白纳米微纤维制得的核部分打印墨水和经化学修饰的柞蚕丝素蛋白纳米微纤维/明胶复合体系制得的壳部分打印墨水进行3D打印制得改性柞蚕丝素蛋白3D打印支架;A preparation method of modified tussah silk fibroin 3D printing scaffold, core part printing ink prepared from chemically modified tussah silk fibroin nano-microfibers and chemically modified tussah silk fibroin nano-microfibers/gelatin composite system The obtained shell part printing ink is 3D printed to obtain a modified tussah silk fibroin 3D printing scaffold;

化学修饰的柞蚕丝素蛋白纳米微纤维是将柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系与化学修饰剂混合后经过一系列反应和操作得到的,可以通过调节柞蚕丝素蛋白与化学修饰剂的反应时间来调控细胞在该支架上的吸附、增殖速度,增殖速率越快,修复速率越快,从而适应不同程度组织损伤对修复速度的需求;对柞蚕丝素蛋白分子链修饰反应时间以及接上的亲水基团不同,会使得支架具有不同的细胞相容性,会使细胞在支架上的增殖速率不同,从而得到具有可控修复速度的支架;The chemically modified tussah silk fibroin nano-microfibers are obtained by mixing the tussah silk fibroin nano-microfibers/boric acid buffer mixed system with chemical modifiers through a series of reactions and operations. The reaction time of the agent to adjust the adsorption and proliferation rate of cells on the scaffold, the faster the proliferation rate, the faster the repair rate, so as to meet the needs of different degrees of tissue damage for the repair rate; The different hydrophilic groups attached will make the scaffolds have different cytocompatibility, which will make the proliferation rate of cells on the scaffolds different, so as to obtain scaffolds with controllable repair speed;

本发明的3D打印方法是通过计算机绘制三维模型,并获取三维模型中各层截面的轮廓数据和填充数据,选取高分子材料制作多份不同的3D打印材料,通过指定尺寸规格的打印喷嘴挤出线条沿不同方向沉积在工作平台上的指定区域中,通过降温使得挤出线条固化成形,实现单层截面结构的制作,按不同方向重复单层截面结构层层堆积的制作完成整个三维模型的3D打印;The 3D printing method of the present invention draws a three-dimensional model through a computer, obtains the contour data and filling data of the cross-section of each layer in the three-dimensional model, selects polymer materials to make multiple copies of different 3D printing materials, and extrudes through a printing nozzle of a specified size specification. The lines are deposited in the designated areas on the working platform in different directions, and the extrusion lines are solidified and formed by cooling down to realize the production of a single-layer cross-sectional structure, and the single-layer cross-sectional structure is repeated in different directions. Print;

其中,核部分打印墨水和壳部分打印墨水从同轴喷嘴装置挤出形成具有核壳结构的打印线条,对于核壳结构打印,如果不同轴,会使得到的支架不均匀,从而会影响其力学性能;Among them, the printing ink of the core part and the printing ink of the shell part are extruded from the coaxial nozzle device to form the printing line with the core-shell structure. For the printing of the core-shell structure, if the axis is different, the obtained scaffold will be uneven, which will affect its mechanical properties;

核部分打印墨水中经化学修饰的柞蚕丝素蛋白纳米微纤维的质量含量大于等于6wt%,否则会坍塌;壳部分打印墨水中经化学修饰的柞蚕丝素蛋白纳米微纤维的质量含量小于等于6wt%,且还含有明胶,柞蚕丝素蛋白纳米微纤维浓度必须在6wt%以内,否则会因其流动性太差,无法与明胶混合均匀;The mass content of chemically modified tussah silk fibroin nanofibers in the core part printing ink is greater than or equal to 6wt%, otherwise it will collapse; the mass content of chemically modified tussah silk fibroin nanofibers in the shell part printing ink is less than or equal to 6wt% %, and also contains gelatin, the concentration of tussah silk fibroin nano-microfibers must be within 6wt%, otherwise it will not be able to mix with gelatin because of its poor fluidity;

核部分打印墨水中经化学修饰的柞蚕丝素蛋白纳米微纤维的质量含量大于等于6wt%,否则会坍塌,这是因为其主要成分是柞蚕丝素蛋白纳米微纤维,柞蚕丝素蛋白纳米微纤维不是以分子状态存在的,相互之间作用力很弱,因此容易散架;所以为了防止其散架,必须在外面包上一层主要成分以分子状态存在、且分子间作用力较强的壳墨水,所以在壳部分打印墨水中使用了以明胶成分为主的柞蚕丝素蛋白纳米微纤维/明胶复合体系;The mass content of chemically modified tussah silk fibroin nano-microfibers in the core part printing ink is greater than or equal to 6wt%, otherwise it will collapse, because its main components are tussah silk fibroin nano-microfibers, tussah silk fibroin nano-microfibers It does not exist in a molecular state, and the interaction force between them is weak, so it is easy to fall apart; so in order to prevent it from falling apart, it is necessary to coat a layer of shell ink with the main components existing in molecular state and strong intermolecular force on the outside, so The tussah silk fibroin nanofiber/gelatin composite system mainly composed of gelatin was used in the printing ink of the shell part;

经化学修饰的柞蚕丝素蛋白纳米微纤维为接枝亲水基团的柞蚕丝素蛋白纳米微纤维,其中,化学修饰的目的在于引入亲水基团,提高支架的亲水性,由于细胞均生长在以水为主体的环境中,因此在柞蚕丝素蛋白纳米微纤维的分子链中引入亲水基团后,会提高其细胞粘附及增殖能力,进而能够提高支架的生物相容性;The chemically modified tussah silk fibroin nanofibers are tussah silk fibroin nanofibers grafted with hydrophilic groups, wherein the purpose of chemical modification is to introduce hydrophilic groups to improve the hydrophilicity of the scaffold. It grows in a water-based environment, so the introduction of hydrophilic groups into the molecular chain of tussah silk fibroin nanofibers will improve its cell adhesion and proliferation ability, thereby improving the biocompatibility of the scaffold;

现有技术中,将诱导多能干细胞(iPSCs)培养于3D打印组织工程支架上时,培养十天后细胞存活率最高可以达到90%左右,细胞增殖率最高可达3000%~4000%。而在本发明的改性柞蚕丝素蛋白纳米微纤维/明胶复合3D打印支架上接种并培养10天后诱导多能干细胞(iPSCs)的存活率为92.0%~99.0%,增殖率为9000%~25000%,与现有技术相比,使用本发明的3D打印墨水打印后iPSCs的存活率和增殖率均明显提高,取得了意料不到的技术效果。In the prior art, when induced pluripotent stem cells (iPSCs) are cultured on 3D-printed tissue engineering scaffolds, the highest cell survival rate can reach about 90% after 10 days of culture, and the highest cell proliferation rate can reach 3000%-4000%. However, the survival rate of induced pluripotent stem cells (iPSCs) was 92.0%-99.0% and the proliferation rate was 9000%-25000 after seeding and culturing on the modified tussah silk fibroin nanofiber/gelatin composite 3D printing scaffold of the present invention for 10 days. %, compared with the prior art, the survival rate and proliferation rate of iPSCs after printing with the 3D printing ink of the present invention are significantly improved, and unexpected technical effects are achieved.

此外,现有技术中,基于家蚕丝素蛋白的3D打印墨水进行打印,得到的支架压缩模量最大可达到5kPa;基于柞蚕丝素蛋白水溶液的3D打印墨水打印出的3D支架,压缩模量在10~50MPa范围内;而本发明打印出来的改性柞蚕丝素蛋白3D支架经质量浓度为0.1~5wt%的京尼平浸泡交联反应24h后的压缩模量为100~600MPa远远超出现有技术中基于家蚕丝素蛋白的3D打印墨水以及基于柞蚕丝素蛋白水溶液的3D打印墨水打印出的3D支架的压缩模量,同样取得了意料不到的技术效果。In addition, in the prior art, the 3D printing ink based on Bombyx mori silk fibroin is printed, and the compressive modulus of the obtained scaffold can reach up to 5kPa; the 3D scaffold printed with the 3D printing ink based on the tussah silk fibroin aqueous solution has a compressive modulus in In the range of 10-50MPa; while the modified tussah silk fibroin 3D scaffold printed by the present invention has a compressive modulus of 100-600MPa after being soaked and cross-linked in genipin with a mass concentration of 0.1-5wt% for 24h. In the prior art, the 3D printing ink based on Bombyx mori silk fibroin and the 3D printing ink based on tussah silk fibroin aqueous solution printed the compressive modulus of the 3D scaffold, which also achieved unexpected technical results.

作为优选的方案:As a preferred solution:

如上所述的一种改性柞蚕丝素蛋白3D打印支架的制备方法,核部分打印墨水的挤出胀大率为0.10~1.00%,动态粘度为300~500cP;壳部分打印墨水的自凝胶化时间为10~60s,挤出胀大率为1~30%,动态粘度为1000~5000cP。A method for preparing a modified tussah silk fibroin 3D printing scaffold as described above, the extrusion expansion rate of the printing ink of the core part is 0.10-1.00%, and the dynamic viscosity is 300-500 cP; the self-gelling of the printing ink of the shell part The melting time is 10-60s, the extrusion expansion rate is 1-30%, and the dynamic viscosity is 1000-5000cP.

如上所述的一种改性柞蚕丝素蛋白3D打印支架的制备方法,壳部分打印墨水的制备过程为:首先将经化学修饰的柞蚕丝素蛋白纳米微纤维、细胞生长因子以及抗生素加入水中,机械搅拌1~3h,然后与明胶混合,静置1~3h后,于35~45℃的温度条件下机械搅拌1~5h,最后超声处理1~60min;The above-mentioned preparation method of a modified tussah silk fibroin 3D printing scaffold, the preparation process of the shell part printing ink is as follows: first, chemically modified tussah silk fibroin nanofibers, cell growth factors and antibiotics are added into water, Mechanical stirring for 1-3 hours, then mixing with gelatin, after standing for 1-3 hours, mechanically stirring for 1-5 hours at a temperature of 35-45°C, and finally ultrasonically treating for 1-60 minutes;

壳部分打印墨水中各组分的质量含量为:经化学修饰的柞蚕丝素蛋白纳米微纤维1~6wt%,明胶14~20wt%,细胞生长因子0.1~1.0wt%,抗生素0.1~1.0wt%,余量为水;The mass content of each component in the shell part printing ink is: chemically modified tussah silk fibroin nano-microfibers 1-6 wt %, gelatin 14-20 wt %, cell growth factor 0.1-1.0 wt %, antibiotic 0.1-1.0 wt % , the balance is water;

核部分打印墨水的制备过程为:将经化学修饰的柞蚕丝素蛋白纳米微纤维、细胞生长因子以及抗生素加入水中,于1~45℃的温度条件下机械搅拌1~3h;The preparation process of the core part printing ink is as follows: adding chemically modified tussah silk fibroin nanofibers, cell growth factors and antibiotics into water, and mechanically stirring for 1-3 hours at a temperature of 1-45°C;

核部分打印墨水中各组分的质量含量为:经化学修饰的柞蚕丝素蛋白纳米微纤维6~20wt%,细胞生长因子0.1~1.0wt%,抗生素0.1~1.0wt%,余量为水。The mass content of each component in the core part printing ink is: chemically modified tussah silk fibroin nano-microfiber 6-20 wt%, cell growth factor 0.1-1.0 wt%, antibiotic 0.1-1.0 wt%, and the balance is water.

由于本发明的支架需要用于体内组织工程,必须做到无毒性,所以壳部分打印墨水和核部分打印墨水中的分散介质采用水,当然也可以采用其他无毒性的溶剂;壳部分打印墨水和核部分打印墨水中,细胞生长因子的作用是提高材料的细胞生长及增殖能力;抗生素的作用是促进iPSCs细胞对于心肌蛋白的表达,促进iPSCs细胞向心肌细胞的转化。Since the scaffold of the present invention needs to be used for in vivo tissue engineering, it must be non-toxic, so the dispersion medium in the printing ink of the shell part and the printing ink of the core part is water, and of course other non-toxic solvents can also be used; In the nuclear part printing ink, the function of cell growth factor is to improve the cell growth and proliferation ability of the material; the function of antibiotics is to promote the expression of cardiac proteins in iPSCs cells, and promote the transformation of iPSCs cells into cardiomyocytes.

如上所述的一种改性柞蚕丝素蛋白3D打印支架的制备方法,所有的细胞生长因子都为成纤维细胞生长因子2;所有的抗生素都为四环素;The above-mentioned preparation method of a modified tussah silk fibroin 3D printing scaffold, all cell growth factors are fibroblast growth factor 2; all antibiotics are tetracycline;

所有的细胞生长因子不仅仅局限于成纤维细胞生长因子2,也可以为其他的物质,如骨形态发生蛋白4等;所有的抗生素不仅仅局限于四环素,也可以为其他物质,如强力霉素等,上述所采用的细胞生长因子和抗生素可以达到提高细胞增殖率、存活率以及向心肌细胞转化的效果,但本专利发明支架所用墨水中可以添加的细胞生长因子和抗生素不仅仅局限于上述两种,在不脱离本发明技术原理的前提下,添加其他细胞生长因子(如骨形态发生蛋白4等)和抗生素(如强力霉素等)也应当视为在本发明的保护范围内。All cell growth factors are not limited to fibroblast growth factor 2, but can also be other substances, such as bone morphogenetic protein 4; all antibiotics are not limited to tetracycline, but can also be other substances, such as doxycycline etc., the above-mentioned cell growth factors and antibiotics can achieve the effect of improving cell proliferation rate, survival rate and transformation to cardiomyocytes, but the cell growth factors and antibiotics that can be added to the ink used in the stent of the present invention are not limited to the above two. The addition of other cell growth factors (such as bone morphogenetic protein 4, etc.) and antibiotics (such as doxycycline, etc.) should also be considered within the protection scope of the present invention without departing from the technical principle of the present invention.

如上所述的一种改性柞蚕丝素蛋白3D打印支架的制备方法,所有的经化学修饰的柞蚕丝素蛋白纳米微纤维的制备步骤如下:The above-mentioned preparation method of a modified tussah silk fibroin 3D printing scaffold, the preparation steps of all chemically modified tussah silk fibroin nano-fibers are as follows:

(1)制备柞蚕丝素蛋白浆粕;(1) prepare tussah silk fibroin pulp;

(2)制备化学修饰剂和柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系;(2) Preparation of chemical modifier and tussah silk fibroin nanofiber/boric acid buffer mixed system;

(2.a)化学修饰剂的制备过程为:将浓度为1mM~1M(M=mol/L)的对苯胺基类有机物乙腈溶液、浓度为1mM~2M的对甲基苯磺酸水溶液以及浓度为1.0mM~1.0M的亚硝酸钠水溶液按1:0.5~4:0.5~2的体积比,在1~4℃的温度条件下经漩涡混合5s后,在同样的温度条件下机械搅拌反应5~30min得到化学修饰剂;所述漩涡混合是指将待混合液体装入试管或小烧瓶中,放在常用的漩涡混合器上震荡;(2.a) The preparation process of the chemical modifier is as follows: acetonitrile solution of p-aniline-based organic compounds with a concentration of 1mM to 1M (M=mol/L), an aqueous solution of p-toluenesulfonic acid with a concentration of 1mM to 2M, and a concentration of It is 1.0mM~1.0M sodium nitrite aqueous solution according to the volume ratio of 1:0.5~4:0.5~2, after mixing by vortex for 5s under the temperature condition of 1~4℃, under the same temperature condition, mechanical stirring reaction 5 The chemical modifier is obtained in ~30min; the vortex mixing means that the liquid to be mixed is put into a test tube or a small flask and shaken on a commonly used vortex mixer;

(2.b)柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系的制备步骤如下:(2.b) The preparation steps of the tussah silk fibroin nanofiber/boric acid buffer mixed system are as follows:

(2.b.1)按1g:50~200mL的质量体积比将柞蚕丝素蛋白浆粕浸入水中,机械搅拌使其分散均匀;(2.b.1) Immerse the tussah silk fibroin pulp in water at a mass-to-volume ratio of 1 g:50 to 200 mL, and mechanically stir to disperse it evenly;

(2.b.2)按柞蚕丝素蛋白浆粕:NaClO=1g:0.001~0.050mol的质量摩尔比在柞蚕丝素蛋白浆粕的水分散体系中加入质量浓度为5~35wt%的NaClO水溶液,在1~60℃的温度条件下机械搅拌,在此过程中,通过持续加入0.5~5.0M的NaOH水溶液使得体系pH值维持在10.0~10.1之间,直至当不加入NaOH水溶液时,体系pH值也可维持在10.0~10.1之间;(2.b.2) According to the mass molar ratio of tussah silk fibroin pulp:NaClO=1g:0.001~0.050mol, add the NaClO aqueous solution with a mass concentration of 5~35wt% to the water dispersion system of tussah silk fibroin pulp , mechanically stirring at a temperature of 1-60 ° C. During this process, the pH value of the system is maintained between 10.0 and 10.1 by continuously adding 0.5-5.0M NaOH aqueous solution until the system pH value is not added when the NaOH aqueous solution is not added. The value can also be maintained between 10.0 and 10.1;

(2.b.3)将体系转移至截留分子量为14000Da的纤维素透析袋中,在去离子水中透析1~3天后,继续在硼酸缓冲液中透析1天,然后经浓缩得到柞蚕丝素蛋白纳米微纤维浓度为1~20wt%的柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系,其中硼酸缓冲液主要由硼酸、氯化钠和水组成,硼酸和氯化钠的浓度分别为100mM和150mM;(2.b.3) Transfer the system to a cellulose dialysis bag with a molecular weight cut-off of 14000 Da, dialyze it in deionized water for 1 to 3 days, continue to dialyze it in boric acid buffer for 1 day, and then concentrate to obtain tussah silk fibroin The tussah silk fibroin nanofiber/boric acid buffer mixed system with the nanofiber concentration of 1-20wt%, wherein the boric acid buffer is mainly composed of boric acid, sodium chloride and water, and the concentrations of boric acid and sodium chloride are 100mM and 100mM respectively. 150mM;

(3)化学修饰;(3) chemical modification;

先将浓度为1~20wt%的柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系与化学修饰剂按1:0.1~2的体积比混合,在冰水浴中机械搅拌反应1~5天,再使用去离子水透析1~3天,提纯并冷冻干燥得到长径比为100~200且直径为10~200nm的经化学修饰的柞蚕丝素蛋白纳米微纤维。First, the tussah silk fibroin nanofiber/boric acid buffer mixed system with a concentration of 1-20wt% was mixed with the chemical modifier in a volume ratio of 1:0.1-2, and the reaction was mechanically stirred in an ice-water bath for 1-5 days, and then Dialysis with deionized water for 1-3 days, purification and freeze-drying to obtain chemically modified tussah silk fibroin nanofibers with an aspect ratio of 100-200 and a diameter of 10-200 nm.

如上所述的一种改性柞蚕丝素蛋白3D打印支架的制备方法,柞蚕丝素蛋白浆粕的制备过程如下:The above-mentioned preparation method of a modified tussah silk fibroin 3D printing scaffold, the preparation process of the tussah silk fibroin pulp is as follows:

(1.1)按1g:50~100mL的质量体积比将柞蚕茧浸入质量浓度为0.05~5.00wt%的Na2CO3水溶液中,煮沸1~5次,每次30~60min,之后将煮过的柞蚕茧用水洗涤并干燥,得到脱胶柞蚕丝纤维;(1.1) Immerse the tussah cocoons in a Na 2 CO 3 aqueous solution with a mass concentration of 0.05-5.00 wt % at a mass-to-volume ratio of 1 g:50-100 mL, boil 1-5 times for 30-60 min each time, and then boil the boiled cocoons The tussah cocoons are washed with water and dried to obtain degummed tussah silk fibers;

(1.2)将干燥后的脱胶柞蚕丝纤维按1g:15~25mL的质量体积比浸入质量浓度为60~100wt%的甲酸水溶液中1~3h;(1.2) immersing the dried degummed tussah silk fibers in an aqueous formic acid solution with a mass concentration of 60 to 100 wt % for 1 to 3 hours at a mass volume ratio of 1 g:15 to 25 mL;

(1.3)在10~60℃的温度条件下匀浆处理1~5min进行粉碎,匀浆速率为5000~15000rpm;(1.3) Under the temperature condition of 10~60℃, homogenize for 1~5min and pulverize, and the homogenization rate is 5000~15000rpm;

(1.4)重复步骤(1.2)和步骤(1.3)1~5次得到柞蚕丝素蛋白浆液;(1.4) repeating step (1.2) and step (1.3) 1 to 5 times to obtain tussah silk fibroin protein slurry;

(1.5)将柞蚕丝素蛋白浆液进行离心、过滤、洗涤和干燥得到柞蚕丝素蛋白浆粕。(1.5) Centrifuging, filtering, washing and drying the tussah silk fibroin pulp to obtain the tussah silk fibroin pulp.

如上所述的一种改性柞蚕丝素蛋白3D打印支架的制备方法,对苯胺基类有机物为对氨基苯甲酸、4-(2-乙氨基)苯胺、对氨基苯乙酮或对氨基苯庚醚。The preparation method of a modified tussah silk fibroin 3D printing scaffold as described above, the p-aniline-based organic compound is p-aminobenzoic acid, 4-(2-ethylamino)aniline, p-aminoacetophenone or p-aminophenheptyl ether.

如上所述的一种改性柞蚕丝素蛋白3D打印支架的制备方法,具有核壳结构的打印线条的核部分和壳部分的直径分别为50~500μm和100~1000μm,且壳部分直径大于核部分直径;打印时,将具有核壳结构的打印线条以层层堆积的方式沉积在玻璃片上;打印的工艺参数为:料筒及针头温度25~37℃,挤出气压10~500KPa,打印速度1~10mm/s,由具有核壳结构的打印线条构成的相邻两打印层间的夹角30~90°,线条间距20~2000μm,沉积层数2~10。The above-mentioned preparation method of a modified tussah silk fibroin 3D printing scaffold, the diameters of the core part and the shell part of the printing lines with the core-shell structure are respectively 50-500 μm and 100-1000 μm, and the diameter of the shell part is larger than that of the core Part of the diameter; when printing, the printing lines with core-shell structure are deposited on the glass sheet in a layer-by-layer manner; the printing process parameters are: barrel and needle temperature 25 ~ 37 ℃, extrusion pressure 10 ~ 500KPa, printing speed 1 to 10 mm/s, the angle between two adjacent printing layers formed by printing lines with a core-shell structure is 30 to 90°, the line spacing is 20 to 2000 μm, and the number of deposition layers is 2 to 10.

通过上述打印工艺条件制得的支架具有相对较为优异的力学性能和生物相容性,但本专利发明支架的打印条件不仅仅局限于上述范围之内,在不脱离本发明技术原理的前提下,对于打印工艺条件基本参数以及打印支架形状的改变也应当视为在本发明的保护范围内。The stent obtained by the above printing process conditions has relatively excellent mechanical properties and biocompatibility, but the printing conditions of the stent of the present invention are not limited to the above range. Changes to the basic parameters of the printing process conditions and the shape of the printing support should also be considered within the protection scope of the present invention.

采用如上任一项所述的一种改性柞蚕丝素蛋白3D打印支架的制备方法制得的改性柞蚕丝素蛋白3D打印支架,由具有核壳结构的打印线条构成,具有核壳结构的打印线条的核部分主要由经化学修饰的柞蚕丝素蛋白纳米微纤维组成,壳部分主要由经化学修饰的柞蚕丝素蛋白纳米微纤维和明胶组成。The modified tussah silk fibroin 3D printing scaffold prepared by the method for preparing a modified tussah silk fibroin 3D printing scaffold as described in any one of the above is composed of printing lines with a core-shell structure, and a The core part of the printed lines is mainly composed of chemically modified tussah silk fibroin nanofibers, and the shell part is mainly composed of chemically modified tussah silk fibroin nanofibers and gelatin.

作为优选的方案:As a preferred solution:

如上所述的改性柞蚕丝素蛋白3D打印支架,其分辨率为0.5~10.0μm。一般高分子材料墨水3D打印过程中都会出现挤出胀大和挤出破裂的现象,针头越细,越容易出现这种现象,分辨率指的是通过该墨水打印可以得到均匀稳定线条的最小直径,也就是说,分辨率值越小,可以得到越细的稳定线条,越不容易出现挤出胀大和挤出破裂现象,打印精度就越高,现有技术制备得到的3D打印支架的分辨率一般为30μm左右,而本发明最终制备得到的改性柞蚕丝素蛋白3D打印支架的分辨率为0.50~10.0μm,证明本发明制备得到的3D打印支架具有更高的打印精度。The modified tussah silk fibroin 3D printed scaffold as described above has a resolution of 0.5-10.0 μm. Generally, the phenomenon of extrusion swelling and extrusion rupture will occur in the 3D printing process of polymer inks. The thinner the needle, the more likely this phenomenon occurs. The resolution refers to the minimum diameter of uniform and stable lines that can be printed by this ink. That is to say, the smaller the resolution value is, the thinner the stable lines can be obtained, the less likely to cause extrusion swelling and extrusion cracking, and the higher the printing accuracy. The resolution of the 3D printing bracket prepared by the prior art is generally average. It is about 30 μm, and the resolution of the modified tussah silk fibroin 3D printing scaffold finally prepared by the present invention is 0.50-10.0 μm, which proves that the 3D printing scaffold prepared by the present invention has higher printing accuracy.

有益效果:Beneficial effects:

(1)本发明的一种改性柞蚕丝素蛋白3D打印支架,其中含有的柞蚕丝素蛋白纳米微纤维可以使支架具有优异的力学性能,该支架的压缩模量相比于目前存在的使用含有丝素蛋白墨水3D打印出的支架可以提高5倍以上;(1) A modified tussah silk fibroin 3D printing scaffold of the present invention, the tussah silk fibroin nano-microfibers contained in the scaffold can make the scaffold have excellent mechanical properties, and the compressive modulus of the scaffold is compared with the existing use 3D printed scaffolds containing silk fibroin ink can be increased by more than 5 times;

(2)本发明的一种改性柞蚕丝素蛋白3D打印支架,其所用墨水中的柞蚕丝素蛋白来自柞蚕茧,柞蚕丝素蛋白中含有RGD链段,该链段具有较好的细胞吸附及增殖能力;将柞蚕丝素蛋白经化学修饰后,具有了更好的表面亲水性。由于细胞一般是生长在以水为主体的环境中,将iPSCs接种在本发明的支架上培养10天后,其存活率及增殖能力相比于目前存在的使用含有家蚕丝素蛋白墨水3D打印出的支架均得到提高,可见本发明的支架具有优异的组织修复能力;(2) A modified tussah silk fibroin 3D printing scaffold of the present invention, the tussah silk fibroin in the ink used is from the cocoon of the tussah silk fibroin, and the tussah silk fibroin contains RGD segments, which have better cell adsorption and proliferation ability; after chemical modification of tussah silk fibroin, it has better surface hydrophilicity. Since cells are generally grown in a water-based environment, after inoculating iPSCs on the scaffold of the present invention for 10 days, their survival rate and proliferation ability are compared with those of existing 3D-printed cells containing Bombyx mori silk fibroin ink. The scaffolds are all improved, and it can be seen that the scaffold of the present invention has excellent tissue repair ability;

(3)本发明的一种改性柞蚕丝素蛋白3D打印支架的制备方法,在经化学修饰的柞蚕丝素蛋白纳米微纤维的制备过程中,NaClO会使柞蚕丝素蛋白分子链发生氧化反应,该氧化反应主要位于分子链中的丝氨酸上;而对柞蚕丝素蛋白分子链的化学修饰反应主要位于分子链中的酪氨酸上,这两个反应均不会对柞蚕丝素蛋白分子链中具有良好细胞相容性的RGD链段造成影响;(3) In the preparation method of a modified tussah silk fibroin 3D printing scaffold of the present invention, in the preparation process of the chemically modified tussah silk fibroin nanofibers, NaClO will cause the tussah silk fibroin molecular chain to undergo an oxidation reaction , the oxidation reaction is mainly located on the serine in the molecular chain; while the chemical modification reaction on the tussah silk fibroin molecular chain is mainly located on the tyrosine in the molecular chain, neither of these two reactions will affect the tussah silk fibroin molecular chain. Influenced by the RGD segment with good cytocompatibility;

(4)本发明的一种改性柞蚕丝素蛋白3D打印支架的制备方法,其所用墨水各成分均以水作为分散剂,因而都具有优异的生物相容性,可与细胞良好地复合并进行3D打印;(4) In the preparation method of a modified tussah silk fibroin 3D printing scaffold of the present invention, each component of the ink used in the ink uses water as a dispersant, so it has excellent biocompatibility and can be well compounded with cells. 3D printing;

(5)本发明的一种改性柞蚕丝素蛋白3D打印支架,打印墨水中所包含的柞蚕丝素蛋白是以纳米微纤维形式存在的,其构象在较宽广的环境条件下可以保持稳定,因此在制备过程中能避免因温度及外力等条件的波动对墨水稳定性产生的不利影响;(5) In a modified tussah silk fibroin 3D printing scaffold of the present invention, the tussah silk fibroin contained in the printing ink exists in the form of nano-fibers, and its conformation can be kept stable under wider environmental conditions, Therefore, the adverse effects on the stability of the ink due to fluctuations in temperature and external force can be avoided during the preparation process;

(6)本发明的一种改性柞蚕丝素蛋白3D打印支架,可以通过调节柞蚕丝素蛋白与化学修饰剂的反应时间来调控细胞在该支架上的吸附、增殖速度,从而适应不同程度组织损伤对修复速度的需求;(6) A modified tussah silk fibroin 3D printing scaffold of the present invention can adjust the adsorption and proliferation speed of cells on the scaffold by adjusting the reaction time of tussah silk fibroin and chemical modifiers, so as to adapt to different degrees of tissue Damage demand for speed of repair;

(7)本发明的一种改性柞蚕丝素蛋白3D打印支架,打印墨水打印过程是在室温到生理温度条件下进行的,因而有利于加载各类生物因子及包埋细胞实现活性打印。(7) In the modified tussah silk fibroin 3D printing scaffold of the present invention, the printing process of the printing ink is carried out under the conditions of room temperature to physiological temperature, which is conducive to loading various biological factors and embedding cells to realize active printing.

具体实施方式Detailed ways

下面结合具体实施方式,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。The present invention will be further described below in conjunction with specific embodiments. It should be understood that these examples are only used to illustrate the present invention and not to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.

实施例1Example 1

一种改性柞蚕丝素蛋白3D打印支架的制备方法,主要步骤如下:A preparation method of a modified tussah silk fibroin 3D printing scaffold, the main steps are as follows:

(1)制备柞蚕丝素蛋白浆粕:(1) Preparation of tussah silk fibroin pulp:

(1.1)按1g:50mL的质量体积比将柞蚕茧浸入质量浓度为0.50wt%的Na2CO3水溶液中,煮沸3次,每次45min,之后将煮过的柞蚕茧用水洗涤并干燥,得到脱胶柞蚕丝纤维;(1.1) Immerse the tussah cocoons in a Na 2 CO 3 aqueous solution with a mass concentration of 0.50 wt % at a mass volume ratio of 1 g:50 mL, boil 3 times for 45 min each time, and then wash the boiled tussah cocoons with water and dry to obtain Degummed tussah silk fibers;

(1.2)将脱胶柞蚕丝纤维按1g:20mL的质量体积比浸入质量浓度为90wt%的甲酸水溶液中2h;(1.2) immersing the degummed tussah silk fiber in an aqueous formic acid solution with a mass concentration of 90wt% for 2h at a mass-volume ratio of 1g:20mL;

(1.3)在25℃的温度条件下匀浆处理2min进行粉碎,匀浆速率为10000rpm;(1.3) Under the temperature condition of 25 ℃, homogenize for 2min and pulverize, and the homogenization rate is 10000rpm;

(1.4)重复步骤(1.2)和步骤(1.3)3次得到柞蚕丝素蛋白浆液;(1.4) repeat step (1.2) and step (1.3) 3 times to obtain tussah silk fibroin slurry;

(1.5)将柞蚕丝素蛋白浆液进行离心、过滤、洗涤和干燥得到柞蚕丝素蛋白浆粕;(1.5) tussah silk fibroin pulp is centrifuged, filtered, washed and dried to obtain tussah silk fibroin pulp;

(2)制备对氨基苯甲酸修饰剂:将浓度为0.2M的对氨基苯甲酸乙腈溶液、浓度为1.6M的对甲基苯磺酸水溶液以及浓度为0.8M的亚硝酸钠水溶液按1:0.5:0.5的体积比在2℃的温度条件下经漩涡混合5s后,在同样的的温度条件下机械搅拌反应15min得到对氨基苯甲酸修饰剂;(2) Preparation of p-aminobenzoic acid modifier: acetonitrile solution of p-aminobenzoic acid with a concentration of 0.2M, an aqueous solution of p-toluenesulfonic acid with a concentration of 1.6M and an aqueous solution of sodium nitrite with a concentration of 0.8M in a ratio of 1:0.5 A volume ratio of 0.5 was mixed by vortexing for 5s under the temperature condition of 2°C, and the p-aminobenzoic acid modifier was obtained by mechanical stirring reaction for 15min under the same temperature condition;

(3)制备柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系:(3) Preparation of tussah silk fibroin nanofiber/boric acid buffer mixed system:

(3.1)按1g:100mL的质量体积比将柞蚕丝素蛋白浆粕浸入水中,机械搅拌使其分散均匀;(3.1) The tussah silk fibroin pulp is immersed in water at a mass volume ratio of 1g:100mL, and mechanically stirred to make it evenly dispersed;

(3.2)按柞蚕丝素蛋白浆粕:NaClO=1g:0.015mol的质量摩尔比在柞蚕丝素蛋白浆粕的水分散体系中加入质量浓度为25wt%的NaClO水溶液,在25℃的温度条件下机械搅拌,在此过程中,通过持续加入1.0M的NaOH水溶液使得体系pH值维持在10.0~10.1之间,直至当不加入NaOH水溶液时,体系pH值也可维持在10.0~10.1之间;(3.2) According to the mass molar ratio of tussah silk fibroin pulp: NaClO=1g:0.015mol, in the water dispersion system of tussah silk fibroin pulp, add a NaClO aqueous solution with a mass concentration of 25wt%, and under the temperature condition of 25°C Mechanical stirring. During this process, the pH value of the system is maintained between 10.0 and 10.1 by continuously adding 1.0M aqueous NaOH solution, until the pH value of the system can also be maintained between 10.0 and 10.1 when no aqueous NaOH solution is added;

(3.3)将体系转移至截留分子量为14000Da的纤维素透析袋中,在去离子水中透析2天后,继续在硼酸缓冲液中透析1天后,再经浓缩得到柞蚕丝素蛋白纳米微纤维浓度为10wt%的柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系,其中硼酸缓冲液主要由硼酸、氯化钠和水组成,硼酸和氯化钠的浓度分别为100mM和150mM;(3.3) Transfer the system to a cellulose dialysis bag with a molecular weight cut-off of 14,000 Da, dialyze it in deionized water for 2 days, continue to dialyze it in boric acid buffer for 1 day, and then concentrate to obtain tussah silk fibroin nanofibers with a concentration of 10wt % Tussah silk fibroin nanofiber/boric acid buffer mixed system, wherein the boric acid buffer is mainly composed of boric acid, sodium chloride and water, and the concentrations of boric acid and sodium chloride are 100mM and 150mM respectively;

(4)制备经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维:先将浓度为10wt%的柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系与对氨基苯甲酸修饰剂按1:0.25的体积比混合,在冰水浴中机械搅拌反应2天,再使用去离子水透析2天提纯并冷冻干燥得到长径比平均为150且平均直径为80nm的经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维;(4) Preparation of p-aminobenzoic acid-modified tussah silk fibroin nanofibers: first, the concentration of 10wt% tussah silk fibroin nano-fibers/boric acid buffer mixed system and p-aminobenzoic acid modifier were 1:0.25 The volume ratio was mixed, the reaction was mechanically stirred in an ice-water bath for 2 days, and then purified by deionized water dialysis for 2 days and freeze-dried to obtain p-aminobenzoic acid-modified tussah silk fibroin with an average aspect ratio of 150 and an average diameter of 80 nm. protein nanofibers;

(5)制备核部分打印墨水:将经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维、成纤维细胞生长因子2以及四环素加入水中,于20℃的温度条件下机械搅拌3h制得核部分打印墨水,其中,核部分打印墨水中各组分的质量含量是:经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维为14wt%,成纤维细胞生长因子2为0.1wt%,四环素为0.4wt%,余量为水;核部分打印墨水挤出胀大率为0.50%,动态粘度为420cP;(5) Preparation of nuclear part printing ink: adding p-aminobenzoic acid-modified tussah silk fibroin nanofibers, fibroblast growth factor 2 and tetracycline into water, and mechanically stirring at 20°C for 3 hours to prepare the core part The printing ink, wherein the mass content of each component in the printing ink of the core part is: 14wt% of tussah silk fibroin nanofibers modified by p-aminobenzoic acid, 0.1wt% of fibroblast growth factor 2, and 0.4 wt% of tetracycline wt%, the balance is water; the extrusion swelling rate of the printing ink in the core part is 0.50%, and the dynamic viscosity is 420cP;

(6)制备壳部分打印墨水:首先将经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维、成纤维细胞生长因子2以及四环素加入水中,机械搅拌3h,然后与明胶混合,静置2h后,于40℃的温度条件下机械搅拌2h,最后超声处理10min制得壳部分打印墨水;其中,壳部分打印墨水中各组分的质量含量是:经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维5wt%,明胶15wt%,成纤维细胞生长因子2为0.1wt%,四环素为0.4wt%,余量为水;壳部分打印墨水的自凝胶化时间为38s,挤出胀大率为10%,动态粘度为3700cP;(6) Preparation of printing ink for shell part: First, add p-aminobenzoic acid-modified tussah silk fibroin nanofibers, fibroblast growth factor 2 and tetracycline into water, stir mechanically for 3 hours, and then mix with gelatin and let stand for 2 hours. , mechanically stirred for 2 hours at a temperature of 40 °C, and finally ultrasonically treated for 10 minutes to obtain a shell part printing ink; wherein, the mass content of each component in the shell part printing ink is: p-aminobenzoic acid modified tussah silk fibroin nanometer Microfiber 5wt%, gelatin 15wt%, fibroblast growth factor 2 is 0.1wt%, tetracycline is 0.4wt%, and the balance is water; the self-gelling time of the shell part printing ink is 38s, and the extrusion swelling rate is 10%, the dynamic viscosity is 3700cP;

(7)先将上述制得核部分打印墨水和壳部分打印墨水从同轴喷嘴装置挤出形成具有核壳结构的打印线条,其中具有核壳结构的打印线条的核部分和壳部分的直径分别为200μm和400μm,再进行3D打印制得改性柞蚕丝素蛋白3D打印支架;打印时,将具有核壳结构的打印线条以层层堆积的方式沉积在玻璃片上;打印的工艺参数为:料筒及针头温度30℃,挤出气压160KPa,打印速度8mm/s,由具有核壳结构的打印线条构成的相邻两打印层间的夹角90°,线条间距400μm,沉积4层。(7) First, the core part printing ink and the shell part printing ink prepared above are extruded from the coaxial nozzle device to form a printing line with a core-shell structure, wherein the diameters of the core part and the shell part of the printing line with the core-shell structure are respectively The modified tussah silk fibroin 3D printing scaffolds were obtained by 3D printing; when printing, the printing lines with core-shell structure were deposited on the glass sheet in a layer-by-layer manner; the printing process parameters were: material The temperature of the cylinder and needle head is 30°C, the extrusion pressure is 160KPa, the printing speed is 8mm/s, the angle between two adjacent printing layers formed by printing lines with a core-shell structure is 90°, the line spacing is 400 μm, and 4 layers are deposited.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为4.6μm;改性柞蚕丝素蛋白3D打印支架经质量浓度为0.5wt%的京尼平浸泡交联反应24h后的压缩模量为336MPa;The final resolution of the modified tussah silk fibroin 3D printed scaffold was 4.6 μm; the compressive modulus of the modified tussah silk fibroin 3D printed scaffold after immersion and cross-linking reaction in genipin with a mass concentration of 0.5 wt% for 24 h is 336MPa;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为99.1%、98.1%、97.7%、95.9%、93.0%,使用细胞计数法,测得细胞增殖率分别为183%、622%、1269%、7678%、17478%。If 1 mL of fetal bovine serum culture medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining method, the cell viability was measured to be 99.1%, 98.1%, 97.7%, 95.9%, and 93.0%, respectively. 622%, 1269%, 7678%, 17478%.

对比例1Comparative Example 1

一种改性柞蚕丝素蛋白3D打印支架的制备方法,其步骤与实施例1基本相同,不同之处在于未经对氨基苯甲酸修饰剂进行修饰,A preparation method of a modified tussah silk fibroin 3D printing scaffold, the steps are basically the same as those in Example 1, the difference is that it is not modified by a p-aminobenzoic acid modifier,

最终制得的改性柞蚕丝素蛋白纳米微纤维长径比为50,平均直径为400nm。The finally prepared modified tussah silk fibroin nanofibers have an aspect ratio of 50 and an average diameter of 400 nm.

核部分打印墨水挤出胀大率为4.00%,动态粘度为100cP。The core part printing ink has an extrusion swell rate of 4.00% and a dynamic viscosity of 100 cP.

壳部分打印墨水自凝胶化时间为60s,挤出胀大率为40%,动态粘度为600cP。The self-gelling time of the shell part printing ink is 60s, the extrusion swelling rate is 40%, and the dynamic viscosity is 600cP.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为30μm;改性柞蚕丝素蛋白3D打印支架经质量浓度为0.5wt%的京尼平浸泡交联反应24h后的压缩模量为80MPa;The resolution of the finally prepared modified tussah silk fibroin 3D printed scaffold was 30 μm; the compressive modulus of the modified tussah silk fibroin 3D printed scaffold after immersion and cross-linking reaction in genipin with a mass concentration of 0.5 wt% for 24 h was 80MPa;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为98.6%、97.6%、97.2%、95.4%、91.5%,使用细胞计数法,测得细胞增殖率分别为125%、256%、468%、1789%、4958%。If 1 mL of fetal bovine serum culture medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining, the cell viability was measured to be 98.6%, 97.6%, 97.2%, 95.4%, and 91.5%, respectively. 256%, 468%, 1789%, 4958%.

将实施例1与对比例1进行对比可以看出,实施例1的改性柞蚕丝素蛋白3D打印支架上的细胞在1、3、4、7、10天后存活率及增殖能力均高于对比例1,且力学性能相对于对比例1来说也得到了提高,这是因为柞蚕丝素蛋白经过化学修饰后,其亲水性和分子链间作用大大提高,随着支架亲水性的提高,其细胞相容性也会得到相应的提高,随着支架分子链间作用提高,其抵抗外界作用力的能力也会得到相应提高,因此,本发明得到的这种改性柞蚕丝素蛋白3D打印支架相比于基于未改性柞蚕丝素蛋白的3D打印支架,其细胞相容性和力学性能可以得到进一步的提高。Comparing Example 1 with Comparative Example 1, it can be seen that the survival rate and proliferation ability of the cells on the modified tussah silk fibroin 3D printing scaffold of Example 1 were higher than those of the control group after 1, 3, 4, 7, and 10 days. Example 1, and the mechanical properties are also improved compared to Comparative Example 1, this is because after chemical modification of tussah silk fibroin, its hydrophilicity and inter-molecular chain interactions are greatly improved. , its cytocompatibility will also be correspondingly improved, with the improvement of the inter-chain interaction of scaffold molecules, its ability to resist external forces will also be correspondingly improved. Therefore, the modified tussah silk fibroin 3D obtained by the present invention Compared with 3D printed scaffolds based on unmodified tussah silk fibroin, the cytocompatibility and mechanical properties of the printed scaffolds can be further improved.

实施例2Example 2

一种改性柞蚕丝素蛋白3D打印支架的制备方法,其步骤与实施例1基本相同,不同之处在于用对氨基苯乙酮修饰剂替换对氨基苯甲酸修饰剂。A method for preparing a modified tussah silk fibroin 3D printing scaffold, the steps of which are basically the same as those in Example 1, except that the p-aminobenzoic acid modifier is replaced by a p-aminoacetophenone modifier.

最终制得的改性柞蚕丝素蛋白纳米微纤维长径比为146,平均直径为86nm。The finally obtained modified tussah silk fibroin nanofibers had an aspect ratio of 146 and an average diameter of 86 nm.

核部分打印墨水挤出胀大率为0.52%,动态粘度为390cP。The core part printing ink has an extrusion swell rate of 0.52% and a dynamic viscosity of 390cP.

壳部分打印墨水自凝胶化时间为39s,挤出胀大率为12%,动态粘度为3500cP。The self-gelling time of the shell part printing ink is 39s, the extrusion swelling rate is 12%, and the dynamic viscosity is 3500cP.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为5.6μm,经0.5wt%的京尼平水溶液浸泡交联反应24h后压缩模量为319MPa;The final obtained modified tussah silk fibroin 3D printing scaffold had a resolution of 5.6 μm, and a compressive modulus of 319 MPa after immersion and cross-linking reaction in 0.5 wt% genipin aqueous solution for 24 h;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为98.9%、97.9%、97.5%、95.7%、92.8%,使用细胞计数法,测得细胞增殖率分别为175%、536%、1045%、5704%、14484%。If 1 mL of fetal bovine serum culture medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining, the cell viability was measured to be 98.9%, 97.9%, 97.5%, 95.7%, and 92.8%, respectively. 536%, 1045%, 5704%, 14484%.

实施例3Example 3

一种改性柞蚕丝素蛋白3D打印支架的制备方法,其步骤与实施例2基本相同,不同之处在于用4-(2-乙氨基)苯胺修饰剂替换对氨基苯乙酮修饰剂。A method for preparing a modified tussah silk fibroin 3D printing scaffold, the steps of which are basically the same as those in Example 2, except that the 4-(2-ethylamino)aniline modifier is used to replace the p-aminoacetophenone modifier.

最终制得的改性柞蚕丝素蛋白纳米微纤维长径比为111,平均直径为126nm。The aspect ratio of the final modified tussah silk fibroin nanofibers was 111, and the average diameter was 126 nm.

核部分打印墨水挤出胀大率为0.62%,动态粘度为350cP。The core part printing ink has an extrusion swell of 0.62% and a dynamic viscosity of 350cP.

壳部分打印墨水自凝胶化时间为42s,挤出胀大率为16%,动态粘度为2900cP。The self-gelling time of the shell part printing ink is 42s, the extrusion swelling rate is 16%, and the dynamic viscosity is 2900cP.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为8.2μm,经0.5wt%的京尼平水溶液浸泡交联反应24h后压缩模量为289MPa;The final obtained modified tussah silk fibroin 3D printed scaffold had a resolution of 8.2 μm, and a compressive modulus of 289 MPa after immersion and cross-linking reaction in 0.5 wt% genipin aqueous solution for 24 h;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为99.4%、98.4%、98.0%、96.2%、92.3%,使用细胞计数法,测得细胞增殖率分别为163%、407%、709%、2743%、9993%。If 1 mL of fetal bovine serum culture medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining method, the cell viability was measured to be 99.4%, 98.4%, 98.0%, 96.2%, and 92.3%, respectively. 407%, 709%, 2743%, 9993%.

实施例4Example 4

一种改性柞蚕丝素蛋白3D打印支架的制备方法,其步骤与实施例3基本相同,不同之处在于用对氨基苯庚醚修饰剂替代4-(2-乙氨基)苯胺修饰剂,A method for preparing a modified tussah silk fibroin 3D printing scaffold, the steps of which are basically the same as those in Example 3, except that the 4-(2-ethylamino)aniline modifier is replaced by a p-aminophenheptyl ether modifier,

最终制得的改性柞蚕丝素蛋白纳米微纤维长径比为132,平均直径为93nm。The finally prepared modified tussah silk fibroin nanofibers had an aspect ratio of 132 and an average diameter of 93 nm.

核部分打印墨水挤出胀大率为0.56%,动态粘度为380cP。The extrusion swelling rate of the core part printing ink is 0.56%, and the dynamic viscosity is 380cP.

壳部分打印墨水自凝胶化时间为41s,挤出胀大率为15%,动态粘度为3200cP。The self-gelling time of the shell part printing ink is 41s, the extrusion swelling rate is 15%, and the dynamic viscosity is 3200cP.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为6.5μm,经0.5wt%的京尼平水溶液浸泡交联反应24h后压缩模量为301MPa;The resolution of the finally prepared modified tussah silk fibroin 3D printing scaffold was 6.5 μm, and the compressive modulus was 301 MPa after immersion and cross-linking reaction in 0.5 wt% genipin aqueous solution for 24 h;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为98.8%、97.8%、97.4%、95.6%、92.7%,使用细胞计数法,测得细胞增殖率分别为171%、493%、933%、4717%、12987%。If 1 mL of fetal bovine serum medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining, the cell viability was measured to be 98.8%, 97.8%, 97.4%, 95.6%, and 92.7%, respectively. 493%, 933%, 4717%, 12987%.

实施例5Example 5

一种改性柞蚕丝素蛋白3D打印支架的制备方法,其步骤与实施例1基本相同,不同之处在于步骤(4)中在冰水浴中机械搅拌反应3天,A method for preparing a modified tussah silk fibroin 3D printing scaffold, the steps of which are basically the same as those in Example 1, except that in step (4), the reaction is mechanically stirred in an ice-water bath for 3 days,

最终制得的改性柞蚕丝素蛋白纳米微纤维长径比为158,平均直径为67nm。The aspect ratio of the final modified tussah silk fibroin nanofibers was 158, and the average diameter was 67 nm.

核部分打印墨水挤出胀大率为0.46%,动态粘度为460cP。The core part printing ink has an extrusion swell rate of 0.46% and a dynamic viscosity of 460cP.

壳部分打印墨水自凝胶化时间为34s,挤出胀大率为8%,动态粘度为4000cP。The self-gelling time of the shell part printing ink is 34s, the extrusion swelling rate is 8%, and the dynamic viscosity is 4000cP.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为2.9μm,经0.5wt%的京尼平水溶液浸泡交联反应24h后压缩模量为354MPa;The final obtained modified tussah silk fibroin 3D printed scaffold had a resolution of 2.9 μm, and a compressive modulus of 354 MPa after immersion and cross-linking reaction in 0.5 wt% genipin aqueous solution for 24 h;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为99.2%、98.2%、97.8%、96.0%、93.1%,使用细胞计数法,测得细胞增殖率分别为187%、665%、1381%、8665%、18975%。If 1 mL of fetal bovine serum medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining method, the cell viability was measured to be 99.2%, 98.2%, 97.8%, 96.0%, and 93.1%, respectively. 665%, 1381%, 8665%, 18975%.

实施例6Example 6

一种改性柞蚕丝素蛋白3D打印支架的制备方法,其步骤与实施例5基本相同,不同之处在于步骤(4)中在冰水浴中机械搅拌反应5天。A method for preparing a modified tussah silk fibroin 3D printing scaffold, the steps of which are basically the same as those in Example 5, except that in step (4), the reaction is mechanically stirred in an ice-water bath for 5 days.

最终制得的改性柞蚕丝素蛋白纳米微纤维长径比为185,平均直径为45nm。The finally prepared modified tussah silk fibroin nanofibers had an aspect ratio of 185 and an average diameter of 45 nm.

核部分打印墨水挤出胀大率为0.42%,动态粘度为490cP。The extrusion swell of the core part printing ink was 0.42%, and the dynamic viscosity was 490cP.

壳部分打印墨水自凝胶化时间为30s,挤出胀大率为5%,动态粘度为4200cP。The self-gelling time of the shell part printing ink is 30s, the extrusion expansion rate is 5%, and the dynamic viscosity is 4200cP.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为1.2μm,经0.5wt%的京尼平水溶液浸泡交联反应24h后压缩模量为443MPa;The resolution of the final modified tussah silk fibroin 3D printed scaffold was 1.2 μm, and the compressive modulus was 443 MPa after immersion and cross-linking reaction in 0.5 wt% genipin aqueous solution for 24 h;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为99.3%、98.3%、97.9%、96.1%、93.3%。使用细胞计数法,测得细胞增殖率分别为191%、708%、1493%、9652%、20473%。If 1 mL of fetal bovine serum medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining, the cell viability was measured to be 99.3%, 98.3%, 97.9%, 96.1% and 93.3%, respectively. Using the cell counting method, the cell proliferation rates were measured to be 191%, 708%, 1493%, 9652%, and 20473%, respectively.

实施例7Example 7

一种改性柞蚕丝素蛋白3D打印支架的制备方法,其步骤与实施例1基本相同,不同之处在于步骤(6)中制备壳部分打印墨水中,经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维的浓度为3wt%、明胶的浓度为17wt%,且打印时使用的核壳结构的打印线条的核部分和壳部分的直径分别为400μm和800μm;打印的工艺参数为:料筒及针头温度32℃,挤出气压130KPa,打印速度8mm/s,线条间距800μm。A method for preparing a modified tussah silk fibroin 3D printing scaffold, the steps of which are basically the same as those in Example 1, the difference is that in the preparation of the shell part printing ink in step (6), the tussah silk fibroin modified by p-aminobenzoic acid is The concentration of protein nanofibers is 3wt%, the concentration of gelatin is 17wt%, and the diameters of the core part and the shell part of the printed lines of the core-shell structure used in printing are 400 μm and 800 μm respectively; the printing process parameters are: barrel And the needle temperature is 32℃, the extrusion pressure is 130KPa, the printing speed is 8mm/s, and the line spacing is 800μm.

壳部分打印墨水自凝胶化时间为46s,挤出胀大率为22%,动态粘度为2000cP。The self-gelling time of the shell part printing ink is 46s, the extrusion swelling rate is 22%, and the dynamic viscosity is 2000cP.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为7.0μm,经0.5wt%的京尼平水溶液浸泡交联反应24h后压缩模量为243MPa;The final obtained modified tussah silk fibroin 3D printed scaffold had a resolution of 7.0 μm, and a compressive modulus of 243 MPa after immersion and cross-linking reaction in 0.5 wt% genipin aqueous solution for 24 h;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为99.0%、98.0%、97.6%、95.8%、92.9%。使用细胞计数法,测得细胞增殖率分别为179%、579%、1157%、6691%、15981%。If 1 mL of fetal bovine serum culture medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining, the cell viability was measured to be 99.0%, 98.0%, 97.6%, 95.8% and 92.9%, respectively. Using the cell counting method, the cell proliferation rates were measured to be 179%, 579%, 1157%, 6691%, and 15981%, respectively.

实施例8Example 8

一种改性柞蚕丝素蛋白3D打印支架的制备方法,其步骤与实施例1基本相同,不同之处在于步骤(6)中制备壳部分打印墨水中,经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维的浓度为1wt%、明胶的浓度为19wt%,且打印时使用的核壳结构的打印线条的核部分和壳部分的直径分别为500μm和1000μm;打印的工艺参数为:料筒及针头温度37℃,挤出气压100KPa,打印速度8mm/s,线条间距2000μm。A method for preparing a modified tussah silk fibroin 3D printing scaffold, the steps of which are basically the same as those in Example 1, the difference is that in the preparation of the shell part printing ink in step (6), the tussah silk fibroin modified by p-aminobenzoic acid is The concentration of protein nanofibers is 1 wt%, the concentration of gelatin is 19 wt%, and the diameters of the core part and the shell part of the printed lines of the core-shell structure used in printing are 500 μm and 1000 μm respectively; the printing process parameters are: barrel And the needle temperature is 37℃, the extrusion pressure is 100KPa, the printing speed is 8mm/s, and the line spacing is 2000μm.

壳部分打印墨水自凝胶化时间为50s,挤出胀大率为26%,动态粘度为1400cP。The self-gelling time of the shell part printing ink is 50s, the extrusion expansion rate is 26%, and the dynamic viscosity is 1400cP.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为9.0μm,经0.5wt%的京尼平水溶液浸泡交联反应24h后压缩模量为196MPa;The resolution of the final modified tussah silk fibroin 3D printed scaffold was 9.0 μm, and the compressive modulus was 196 MPa after immersion and cross-linking reaction in 0.5 wt% genipin aqueous solution for 24 h;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为98.7%、97.7%、97.3%、95.5%、92.6%。使用细胞计数法,测得细胞增殖率分别为167%、450%、821%、3730%、11490%。If 1 mL of fetal bovine serum medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining, the cell viability was measured to be 98.7%, 97.7%, 97.3%, 95.5%, and 92.6%, respectively. Using the cell counting method, the cell proliferation rates were measured to be 167%, 450%, 821%, 3730%, and 11490%, respectively.

实施例9Example 9

一种改性柞蚕丝素蛋白3D打印支架的制备方法,主要步骤如下:A preparation method of a modified tussah silk fibroin 3D printing scaffold, the main steps are as follows:

(1)制备柞蚕丝素蛋白浆粕:(1) Preparation of tussah silk fibroin pulp:

(1.1)按1g:100mL的质量体积比将柞蚕茧浸入质量浓度为5.00wt%的Na2CO3水溶液中,煮沸5次,每次60min,之后将煮过的柞蚕茧用水洗涤并干燥,得到脱胶柞蚕丝纤维;(1.1) Immerse the tussah cocoons in a Na 2 CO 3 aqueous solution with a mass concentration of 5.00 wt % at a mass-to-volume ratio of 1 g:100 mL, boil 5 times for 60 min each time, and then wash the boiled tussah cocoons with water and dry to obtain Degummed tussah silk fiber;

(1.2)将脱胶柞蚕丝纤维按1g:25mL的质量体积比浸入质量浓度为100wt%的甲酸水溶液中3h;(1.2) immersing the degummed tussah silk fiber in an aqueous formic acid solution with a mass concentration of 100 wt % for 3 h at a mass volume ratio of 1 g:25 mL;

(1.3)在改成60℃的温度条件下匀浆处理5min进行粉碎,匀浆速率为15000rpm;(1.3) Under the temperature condition of changing to 60 ℃, homogenize treatment for 5min and pulverize, and the homogenization rate is 15000rpm;

(1.4)重复步骤(1.2)和步骤(1.3)5次得到柞蚕丝素蛋白浆液;(1.4) repeat step (1.2) and step (1.3) 5 times to obtain tussah silk fibroin slurry;

(1.5)将柞蚕丝素蛋白浆液进行离心、过滤、洗涤和干燥得到柞蚕丝素蛋白浆粕;(1.5) tussah silk fibroin pulp is centrifuged, filtered, washed and dried to obtain tussah silk fibroin pulp;

(2)制备化学修饰剂:将浓度为1mM的4-(2-乙氨基)苯胺乙腈溶液、浓度为1mM的对甲基苯磺酸水溶液以及浓度为1mM的亚硝酸钠水溶液按1:4:2的体积比在1℃的温度条件下经漩涡混合5s后,在同样的温度条件下机械搅拌反应5min得到化学修饰剂;(2) Preparation of chemical modifier: 4-(2-ethylamino)aniline acetonitrile solution with a concentration of 1 mM, p-toluenesulfonic acid aqueous solution with a concentration of 1 mM and sodium nitrite aqueous solution with a concentration of 1 mM in a ratio of 1:4: After the volume ratio of 2 was mixed by vortex for 5s under the temperature condition of 1℃, the chemical modifier was obtained by mechanical stirring reaction for 5min under the same temperature condition;

(3)制备柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系:(3) Preparation of tussah silk fibroin nanofiber/boric acid buffer mixed system:

(3.1)按1g:200mL的质量体积比将柞蚕丝素蛋白浆粕浸入水中,机械搅拌使其分散均匀;(3.1) Immerse the tussah silk fibroin pulp in water at a mass-to-volume ratio of 1g:200mL, and mechanically stir to disperse it evenly;

(3.2)按柞蚕丝素蛋白浆粕:NaClO=1g:0.001mol的质量摩尔比在柞蚕丝素蛋白浆粕的水分散体系中加入质量浓度为5wt%的NaClO水溶液,在1℃的温度条件下机械搅拌,在此过程中,通过持续加入0.5M的NaOH水溶液使得体系pH值维持在10.0~10.1之间,直至当不加入NaOH水溶液时,体系pH值也可维持在10.0~10.1之间;(3.2) According to the mass molar ratio of tussah silk fibroin pulp: NaClO=1 g: 0.001 mol, a NaClO aqueous solution with a mass concentration of 5 wt% was added to the water dispersion system of tussah silk fibroin pulp, and at a temperature of 1 °C Mechanical stirring. During this process, the pH value of the system is maintained between 10.0 and 10.1 by continuously adding 0.5M aqueous NaOH solution, until the pH value of the system can also be maintained between 10.0 and 10.1 when no aqueous NaOH solution is added;

(3.3)将体系转移至截留分子量为14000Da的纤维素透析袋中,在去离子水中透析1天后,继续在硼酸缓冲液中透析1天,再经浓缩得到柞蚕丝素蛋白纳米微纤维浓度为1wt%的柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系,其中硼酸缓冲液主要由硼酸、氯化钠和水组成,硼酸和氯化钠的浓度分别为100mM和150mM;(3.3) Transfer the system to a cellulose dialysis bag with a molecular weight cut-off of 14,000 Da, dialyze it in deionized water for 1 day, continue dialysis in boric acid buffer for 1 day, and then concentrate to obtain tussah silk fibroin nanofibers with a concentration of 1wt % Tussah silk fibroin nanofiber/boric acid buffer mixed system, wherein the boric acid buffer is mainly composed of boric acid, sodium chloride and water, and the concentrations of boric acid and sodium chloride are 100mM and 150mM respectively;

(4)制备经4-(2-乙氨基)苯胺修饰的柞蚕丝素蛋白纳米微纤维:先将浓度为1wt%的柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系与经4-(2-乙氨基)苯胺修饰剂按12的体积比混合,在冰水浴中机械搅拌反应1天,再使用去离子水透析1天提纯并冷冻干燥得到长径比平均为100且平均直径为200nm的经经4-(2-乙氨基)苯胺修饰的柞蚕丝素蛋白纳米微纤维;(4) Preparation of tussah silk fibroin nanofibers modified with 4-(2-ethylamino)aniline: First, the tussah silk fibroin nanofibers/boric acid buffer mixed system with a concentration of 1 wt% was mixed with 4-(2 -Ethylamino)aniline modifier was mixed in a volume ratio of 12, reacted with mechanical stirring in an ice-water bath for 1 day, and then dialyzed with deionized water for 1 day to purify and freeze-dry to obtain an average length-diameter ratio of 100 and an average diameter of 200nm. Tussah silk fibroin nanofibers modified by 4-(2-ethylamino)aniline;

(5)制备核部分打印墨水:将经经4-(2-乙氨基)苯胺修饰的柞蚕丝素蛋白纳米微纤维、成纤维细胞生长因子2以及四环素加入水中,于1℃的温度条件下机械搅拌1h制得核部分打印墨水,其中,核部分打印墨水中各组分的质量含量是:经经4-(2-乙氨基)苯胺修饰的柞蚕丝素蛋白纳米微纤维为6wt%,成纤维细胞生长因子2为0.1wt%,四环素为0.1wt%,余量为水;核部分打印墨水挤出胀大率为1.00%,动态粘度为300cP;(5) Preparation of nuclear part printing ink: tussah silk fibroin nanofibers modified with 4-(2-ethylamino)aniline, fibroblast growth factor 2 and tetracycline were added to water, and the mechanical The core part printing ink was prepared by stirring for 1 hour, wherein the mass content of each component in the core part printing ink was: the tussah silk fibroin nano-microfibers modified by 4-(2-ethylamino)aniline were 6 wt %, and the fibrous The cell growth factor 2 is 0.1wt%, the tetracycline is 0.1wt%, and the balance is water; the extrusion swelling rate of the core part printing ink is 1.00%, and the dynamic viscosity is 300cP;

(6)制备壳部分打印墨水:首先将经经4-(2-乙氨基)苯胺修饰的柞蚕丝素蛋白纳米微纤维、成纤维细胞生长因子2以及四环素加入水中,机械搅拌1h,然后与明胶混合,静置1h后,于35℃的温度条件下机械搅拌1h,最后超声处理1min制得壳部分打印墨水;其中,壳部分打印墨水中各组分的质量含量是:经经4-(2-乙氨基)苯胺修饰的柞蚕丝素蛋白纳米微纤维为1wt%,明胶为14wt%,成纤维细胞生长因子2为0.1wt%,四环素为0.1wt%,余量为水;壳部分打印墨水的自凝胶化时间为60s,挤出胀大率为30%,动态粘度为1000cP;(6) Preparation of shell part printing ink: firstly add tussah silk fibroin nanofibers modified with 4-(2-ethylamino)aniline, fibroblast growth factor 2 and tetracycline into water, stir mechanically for 1 h, then mix with gelatin Mixing, after standing for 1 h, mechanically stirring for 1 h at a temperature of 35 ° C, and finally ultrasonically treating for 1 min to obtain the shell part printing ink; wherein, the mass content of each component in the shell part printing ink is: after 4-(2 -Ethylamino)aniline-modified tussah silk fibroin nanofibers were 1wt%, gelatin was 14wt%, fibroblast growth factor 2 was 0.1wt%, tetracycline was 0.1wt%, and the balance was water; The self-gelling time is 60s, the extrusion expansion rate is 30%, and the dynamic viscosity is 1000cP;

(7)先将上述制得核部分打印墨水和壳部分打印墨水从同轴喷嘴装置挤出形成具有核壳结构的打印线条,其中具有核壳结构的打印线条的核部分和壳部分的直径分别为500μm和1000μm,再进行3D打印制得改性柞蚕丝素蛋白3D打印支架;打印时,将具有核壳结构的打印线条以层层堆积的方式沉积在玻璃片上;打印的工艺参数为:料筒及针头温度25℃,挤出气压10KPa,打印速度10mm/s,由具有核壳结构的打印线条构成的相邻两打印层间的夹角30°,线条间距2000μm,沉积2层。(7) First, the core part printing ink and the shell part printing ink prepared above are extruded from the coaxial nozzle device to form a printing line with a core-shell structure, wherein the diameters of the core part and the shell part of the printing line with the core-shell structure are respectively The modified tussah silk fibroin 3D printing scaffolds were obtained by 3D printing; when printing, the printing lines with core-shell structure were deposited on the glass sheet in a layer-by-layer manner; the printing process parameters were: material The temperature of the barrel and needle head was 25°C, the extrusion pressure was 10KPa, the printing speed was 10mm/s, the angle between two adjacent printing layers formed by printing lines with a core-shell structure was 30°, the line spacing was 2000 μm, and 2 layers were deposited.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为10.0μm;改性柞蚕丝素蛋白3D打印支架经质量浓度为5.0wt%的京尼平浸泡交联反应24h后的压缩模量为100MPa;The resolution of the final modified tussah silk fibroin 3D printed scaffold was 10.0 μm; the compressive modulus of the modified tussah silk fibroin 3D printed scaffold after immersion and cross-linking reaction in genipin with a mass concentration of 5.0 wt% for 24 h is 100MPa;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为98.7%、97.6%、97.3%、95.5%和92.0%,使用细胞计数法,测得细胞增殖率分别为150%、344%、564%、3158%和9000%。If 1 mL of fetal bovine serum medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining, the cell viability was measured to be 98.7%, 97.6%, 97.3%, 95.5% and 92.0%, respectively. 344%, 564%, 3158% and 9000%.

实施例10Example 10

一种改性柞蚕丝素蛋白3D打印支架的制备方法,主要步骤如下:A preparation method of a modified tussah silk fibroin 3D printing scaffold, the main steps are as follows:

(1)制备柞蚕丝素蛋白浆粕:(1) Preparation of tussah silk fibroin pulp:

(1.1)按1g:50mL的质量体积比将柞蚕茧浸入质量浓度为0.05wt%的Na2CO3水溶液中,煮沸1次,每次30min,之后将煮过的柞蚕茧用水洗涤并干燥,得到脱胶柞蚕丝纤维;(1.1) Immerse the tussah cocoons in a Na 2 CO 3 aqueous solution with a mass concentration of 0.05 wt % at a mass volume ratio of 1 g:50 mL, boil once for 30 min each time, and then wash the boiled tussah cocoons with water and dry to obtain Degummed tussah silk fibers;

(1.2)将脱胶柞蚕丝纤维按1g:15mL的质量体积比浸入质量浓度为60wt%的甲酸水溶液中1h;(1.2) immersing the degummed tussah silk fiber in an aqueous formic acid solution with a mass concentration of 60wt% for 1h at a mass volume ratio of 1g:15mL;

(1.3)在10℃的温度条件下匀浆处理1min进行粉碎,匀浆速率为5000rpm;(1.3) Under the temperature condition of 10 ℃, homogenize for 1min and pulverize, and the homogenization rate is 5000rpm;

(1.4)重复步骤(1.2)和步骤(1.3)1次得到柞蚕丝素蛋白浆液;(1.4) repeating step (1.2) and step (1.3) once to obtain tussah silk fibroin protein slurry;

(1.5)将柞蚕丝素蛋白浆液进行离心、过滤、洗涤和干燥得到柞蚕丝素蛋白浆粕;(1.5) tussah silk fibroin pulp is centrifuged, filtered, washed and dried to obtain tussah silk fibroin pulp;

(2)制备化学修饰剂:将浓度为1M的对氨基苯甲酸乙腈溶液、浓度为2M的对甲基苯磺酸水溶液以及浓度为1M的亚硝酸钠水溶液按1:2:2的体积比在4℃的温度条件下经漩涡混合5s后,在同样的温度条件下机械搅拌反应30min得到化学修饰剂;(2) Preparation of chemical modifier: 1M p-aminobenzoic acid acetonitrile solution, 2M p-toluenesulfonic acid aqueous solution and 1M sodium nitrite aqueous solution in a volume ratio of 1:2:2 After vortex mixing for 5s under the temperature condition of 4℃, the chemical modifier was obtained by mechanical stirring reaction for 30min under the same temperature condition;

(3)制备柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系:(3) Preparation of tussah silk fibroin nanofiber/boric acid buffer mixed system:

(3.1)按1g:50mL的质量体积比将柞蚕丝素蛋白浆粕浸入水中,机械搅拌使其分散均匀;(3.1) Immerse the tussah silk fibroin pulp in water at a mass-volume ratio of 1g:50mL, and mechanically stir to disperse it evenly;

(3.2)按柞蚕丝素蛋白浆粕:NaClO=1g:0.050mol的质量摩尔比在柞蚕丝素蛋白浆粕的水分散体系中加入质量浓度为35wt%的NaClO水溶液,在60℃的温度条件下机械搅拌,在此过程中,通过持续加入5.0M的NaOH水溶液使得体系pH值维持在10.0~10.1之间,直至当不加入NaOH水溶液时,体系pH值也可维持在10.0~10.1之间;(3.2) According to the mass molar ratio of tussah silk fibroin pulp: NaClO=1g:0.050mol, in the water dispersion system of tussah silk fibroin pulp, add a NaClO aqueous solution with a mass concentration of 35wt%, and under the temperature condition of 60 ° C Mechanical stirring. During this process, the pH value of the system is maintained between 10.0 and 10.1 by continuously adding 5.0M aqueous NaOH solution, until the pH value of the system can also be maintained between 10.0 and 10.1 when no aqueous NaOH solution is added;

(3.3)将体系转移至截留分子量为14000Da的纤维素透析袋中,在去离子水中透析3天后,继续在硼酸缓冲液中透析1天后,再经浓缩得到柞蚕丝素蛋白纳米微纤维浓度为20wt%的柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系,其中硼酸缓冲液主要由硼酸、氯化钠和水组成,硼酸和氯化钠的浓度分别为100mM和150mM;(3.3) Transfer the system to a cellulose dialysis bag with a molecular weight cut-off of 14,000 Da, dialyze it in deionized water for 3 days, continue dialysis in boric acid buffer for 1 day, and then concentrate to obtain tussah silk fibroin nanofibers with a concentration of 20wt % Tussah silk fibroin nanofiber/boric acid buffer mixed system, wherein the boric acid buffer is mainly composed of boric acid, sodium chloride and water, and the concentrations of boric acid and sodium chloride are 100mM and 150mM respectively;

(4)制备经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维:先将浓度为20wt%的柞蚕丝素蛋白纳米微纤维/硼酸缓冲液混合体系与对氨基苯甲酸修饰剂按1:0.1的体积比混合,在冰水浴中机械搅拌反应5天,再使用去离子水透析3天提纯并冷冻干燥得到长径比平均为200且平均直径为10nm的经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维;(4) Preparation of p-aminobenzoic acid-modified tussah silk fibroin nanofibers: first, mix the tussah silk fibroin nanofibers/boric acid buffer mixture system with a concentration of 20wt% and p-aminobenzoic acid modifier at a ratio of 1:0.1 The volume ratio was mixed, and the reaction was mechanically stirred in an ice-water bath for 5 days, and then dialyzed with deionized water for 3 days to purify and freeze-dry to obtain p-aminobenzoic acid-modified tussah silk with an average aspect ratio of 200 and an average diameter of 10 nm. protein nanofibers;

(5)制备核部分打印墨水:将将经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维、成纤维细胞生长因子2以及四环素加入水中,于45℃的温度条件下机械搅拌3h制得核部分打印墨水,其中,核部分打印墨水中各组分的质量含量是:经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维为20wt%,成纤维细胞生长因子2为1wt%,四环素为1wt%,余量为水;核部分打印墨水的挤出胀大率为0.10%,动态粘度为500cP;(5) Preparation of nuclear part printing ink: adding p-aminobenzoic acid-modified tussah silk fibroin nanofibers, fibroblast growth factor 2 and tetracycline into water, and mechanically stirring at 45°C for 3 hours to prepare the nucleus Part of the printing ink, wherein the mass content of each component in the core part of the printing ink is: 20wt% of tussah silk fibroin nanofibers modified with p-aminobenzoic acid, 1wt% of fibroblast growth factor 2, and 1wt% of tetracycline %, the balance is water; the extrusion expansion rate of the printing ink in the core part is 0.10%, and the dynamic viscosity is 500cP;

(6)制备壳部分打印墨水:首先将经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维、成纤维细胞生长因子2以及四环素加入水中,机械搅拌3h,然后与明胶混合,静置3h后,于45℃的温度条件下机械搅拌5h,最后超声处理60min制得壳部分打印墨水;其中,壳部分打印墨水中各组分的质量含量是:经对氨基苯甲酸修饰的柞蚕丝素蛋白纳米微纤维为6wt%,明胶为20wt%,成纤维细胞生长因子2为1wt%,四环素1wt%,余量为水;壳部分打印墨水的自凝胶化时间为10s,挤出胀大率为1%,动态粘度为5000cP;(6) Preparation of printing ink for shell part: first, add p-aminobenzoic acid-modified tussah silk fibroin nanofibers, fibroblast growth factor 2 and tetracycline into water, stir mechanically for 3 hours, and then mix with gelatin and let stand for 3 hours. , mechanically stirred for 5 hours at a temperature of 45°C, and finally ultrasonically treated for 60 minutes to obtain a shell part printing ink; wherein, the mass content of each component in the shell part printing ink is: tussah silk fibroin nanometer modified with p-aminobenzoic acid Microfibers are 6wt%, gelatin is 20wt%, fibroblast growth factor 2 is 1wt%, tetracycline is 1wt%, and the balance is water; the self-gelling time of the shell part printing ink is 10s, and the extrusion swelling ratio is 1 %, the dynamic viscosity is 5000cP;

(7)先将上述制得核部分打印墨水和壳部分打印墨水从同轴喷嘴装置挤出形成具有核壳结构的打印线条,其中具有核壳结构的打印线条的核部分和壳部分的直径分别为50μm和100μm,再进行3D打印制得改性柞蚕丝素蛋白3D打印支架;打印时,将具有核壳结构的打印线条以层层堆积的方式沉积在玻璃片上;打印的工艺参数为:料筒及针头温度37℃,挤出气压500KPa,打印速度1mm/s,由具有核壳结构的打印线条构成的相邻两打印层间的夹角90°,线条间距20μm,沉积10层。(7) First, the core part printing ink and the shell part printing ink prepared above are extruded from the coaxial nozzle device to form a printing line with a core-shell structure, wherein the diameters of the core part and the shell part of the printing line with the core-shell structure are respectively The modified tussah silk fibroin 3D printing scaffolds were obtained by 3D printing; when printing, the printing lines with core-shell structure were deposited on the glass sheet in a layer-by-layer manner; the printing process parameters were: material The temperature of the barrel and needle head was 37°C, the extrusion pressure was 500KPa, the printing speed was 1mm/s, the angle between two adjacent printing layers formed by printing lines with a core-shell structure was 90°, the line spacing was 20 μm, and 10 layers were deposited.

最终制得的改性柞蚕丝素蛋白3D打印支架的分辨率为0.5μm;改性柞蚕丝素蛋白3D打印支架经质量浓度为0.1wt%的京尼平浸泡交联反应24h后的压缩模量为600MPa;The resolution of the final modified tussah silk fibroin 3D printed scaffold was 0.5 μm; the compressive modulus of the modified tussah silk fibroin 3D printed scaffold after immersion and cross-linking reaction in genipin with a mass concentration of 0.1 wt% for 24 h is 600MPa;

若将1mL含有10000个二代iPSCs的胎牛血清培养液接种于直径为15mm的按照如上述方法打印并交联的支架上,并在37.0℃、5.0%CO2条件下培养1、3、4、7、10天后,使用台盼蓝染色法,测得细胞存活率分别为99.9%、99.7%、99.5%、99.2%和99.0%,使用细胞计数法,测得细胞增殖率分别为240%、864%、1821%、11775%和25000%。If 1 mL of fetal bovine serum culture medium containing 10,000 second-generation iPSCs was inoculated on a 15 mm diameter scaffold printed and cross-linked as described above, and cultured at 37.0°C, 5.0% CO 2 for 1, 3, 4 , 7 and 10 days later, using trypan blue staining method, the cell viability was measured to be 99.9%, 99.7%, 99.5%, 99.2% and 99.0%, respectively. 864%, 1821%, 11775% and 25000%.

以上所述仅仅是本发明的实施方式举例。对于本技术领域的普通技术人员来说,在不脱离本发明技术原理的前提下,仍可以做出若干改进和变形。例如:打印墨水配方及制备工艺条件的改变,打印工艺的改变(针头直径、打印温度、挤出气压、打印速度、层间夹角、线条间距、沉积层数等)、打印支架处理方式的改变等,这些也应当视为本发明的保护范围。The above are merely examples of embodiments of the present invention. For those skilled in the art, several improvements and modifications can still be made without departing from the technical principles of the present invention. For example: change of printing ink formulation and preparation process conditions, change of printing process (needle diameter, printing temperature, extrusion pressure, printing speed, interlayer angle, line spacing, number of deposited layers, etc.), change of printing support processing method etc., these should also be regarded as the protection scope of the present invention.

Claims (10)

1. A preparation method of a modified tussah silk fibroin 3D printing support is characterized by comprising the following steps: performing 3D printing on core part printing ink prepared from the chemically modified tussah silk fibroin nano microfiber and shell part printing ink prepared from a chemically modified tussah silk fibroin nano microfiber/gelatin composite system to obtain a modified tussah silk fibroin 3D printing support;
the core part printing ink and the shell part printing ink are extruded from the coaxial nozzle device to form a printing line with a core-shell structure;
the mass content of the chemically modified tussah silk fibroin nano microfibers in the core part printing ink is more than or equal to 6 wt%, and the mass content of the chemically modified tussah silk fibroin nano microfibers in the shell part printing ink is less than or equal to 6 wt%;
the chemically modified tussah silk fibroin nano microfiber is tussah silk fibroin nano microfiber grafted with a hydrophilic group;
the modified tussah silk fibroin 3D printing support has the compression modulus of 100-600 MPa after being soaked in genipin with the mass concentration of 0.1-5 wt% for crosslinking reaction for 24 hours, the survival rate of induced pluripotent stem cells after being cultured for 10 days is 92.0-99.0%, and the proliferation rate is 9000-25000%.
2. The preparation method of the modified tussah silk fibroin 3D printing bracket as claimed in claim 1, wherein the extrusion swelling rate of the core printing ink is 0.10-1.00%, and the dynamic viscosity is 300-500 cP; the self-gelling time of the shell printing ink is 10-60 s, the extrusion swelling rate is 1-30%, and the dynamic viscosity is 1000-5000 cP.
3. The preparation method of the modified tussah silk fibroin 3D printing bracket as claimed in claim 2, wherein the shell printing ink is prepared by the following steps: firstly, adding chemically modified tussah silk fibroin nano microfibers, cell growth factors and antibiotics into water, mechanically stirring for 1-3 hours, then mixing with gelatin, standing for 1-3 hours, mechanically stirring for 1-5 hours at the temperature of 35-45 ℃, and finally carrying out ultrasonic treatment for 1-60 min;
the shell printing ink comprises the following components in percentage by mass: 1-6 wt% of chemically modified tussah silk fibroin nano microfiber, 14-20 wt% of gelatin, 0.1-1.0 wt% of cell growth factor, 0.1-1.0 wt% of antibiotic and the balance of water;
the preparation process of the core part printing ink comprises the following steps: adding the chemically modified tussah silk fibroin nano microfiber, a cell growth factor and an antibiotic into water, and mechanically stirring for 1-3 hours at the temperature of 1-45 ℃;
the mass content of each component in the core part printing ink is as follows: 6-20 wt% of chemically modified tussah silk fibroin nano microfiber, 0.1-1.0 wt% of cell growth factor, 0.1-1.0 wt% of antibiotic and the balance of water.
4. The method for preparing the modified tussah silk fibroin 3D printing scaffold as claimed in claim 3, wherein all cell growth factors are fibroblast growth factor 2; all antibiotics were tetracyclines.
5. The preparation method of the modified tussah silk fibroin 3D printing scaffold as claimed in claim 1, wherein all chemically modified tussah silk fibroin nano-microfibers are prepared by the following steps:
(1) preparing tussah silk fibroin pulp;
(2) preparing a chemical modifier and a tussah silk fibroin nano microfiber/boric acid buffer solution mixed system;
(2.a) the preparation process of the chemical modifier comprises the following steps: carrying out vortex mixing on a p-phenylenediamine group organic acetonitrile solution with the concentration of 1 mM-1M, a p-toluenesulfonic acid aqueous solution with the concentration of 1 mM-2M and a sodium nitrite aqueous solution with the concentration of 1.0 mM-1.0M for 5s at the temperature of 1-4 ℃ according to the volume ratio of 1: 0.5-4: 0.5-2, and then carrying out mechanical stirring reaction for 5-30 min at the same temperature to obtain a chemical modifier;
(2, b) the preparation method of the tussah silk fibroin nano microfiber/boric acid buffer solution mixed system comprises the following steps:
(2, b.1) soaking the tussah silk fibroin pulp in water according to the mass volume ratio of 1g: 50-200 mL, and mechanically stirring to uniformly disperse the tussah silk fibroin pulp;
(2, b.2) adding a NaClO aqueous solution with the mass concentration of 5-35 wt% into an aqueous dispersion system of the tussah silk fibroin pulp according to the mass molar ratio of the tussah silk fibroin pulp to the NaClO of 1g: 0.001-0.050 mol, and mechanically stirring at the temperature of 1-60 ℃, wherein in the process, the pH value of the system is kept between 10.0-10.1 by continuously adding 0.5-5.0M of NaOH aqueous solution until the pH value of the system can be kept between 10.0-10.1 when no NaOH aqueous solution is added;
(2, b.3) transferring the system into a cellulose dialysis bag with the molecular weight cutoff of 14000Da, dialyzing in deionized water for 1-3 days, continuing to dialyze in a boric acid buffer solution for 1 day, and concentrating to obtain a tussah silk fibroin nano microfiber/boric acid buffer solution mixed system with the concentration of 1-20 wt% of the tussah silk fibroin nano microfiber, wherein the boric acid buffer solution mainly comprises boric acid, sodium chloride and water, and the concentrations of the boric acid and the sodium chloride are 100mM and 150mM respectively;
(3) chemical modification;
the method comprises the steps of mixing a 1-20 wt% tussah silk fibroin nano microfiber/boric acid buffer solution mixed system with a chemical modifier according to a volume ratio of 1: 0.1-2, mechanically stirring and reacting in an ice water bath for 1-5 days, dialyzing with deionized water for 1-3 days, purifying, and freeze-drying to obtain the chemically modified tussah silk fibroin nano microfiber with the length-diameter ratio of 100-200 and the diameter of 10-200 nm.
6. The preparation method of the modified tussah silk fibroin 3D printing bracket as claimed in claim 5, wherein the tussah silk fibroin pulp is prepared by the following steps:
(1.1) immersing the tussah cocoons into Na with the mass concentration of 0.05-5.00 wt% according to the mass-volume ratio of 1g to 50-100 mL2CO3Aqueous solutionBoiling for 1-5 times, each time for 30-60 min, and then washing and drying the boiled tussah cocoons with water to obtain degummed tussah silk fibers;
(1.2) immersing the dried degummed tussah silk fiber into a formic acid aqueous solution with the mass concentration of 60-100 wt% for 1-3 h according to the mass volume ratio of 1g: 15-25 mL;
(1.3) homogenizing at the temperature of 10-60 ℃ for 1-5 min, and crushing, wherein the homogenizing speed is 5000-15000 rpm;
(1.4) repeating the step (1.2) and the step (1.3) for 1-5 times to obtain tussah silk fibroin slurry;
and (1.5) centrifuging, filtering, washing and drying the tussah silk fibroin slurry to obtain the tussah silk fibroin pulp.
7. The preparation method of the modified tussah silk fibroin 3D printing support according to claim 5, wherein the para-anilino organic compound is para-aminobenzoic acid, 4- (2-ethylamino) aniline, para-aminoacetophenone or para-aminophenazone.
8. The preparation method of the modified tussah silk fibroin 3D printing bracket according to claim 1, wherein the diameters of the core part and the shell part of the printing line with the core-shell structure are 50-500 μm and 100-1000 μm respectively, and the diameter of the shell part is larger than that of the core part; during printing, the printing lines with the core-shell structure are deposited on a glass sheet in a layer-by-layer stacking manner; the printing process parameters are as follows: the temperature of the charging barrel and the temperature of the needle head are 25-37 ℃, the extrusion air pressure is 10-500 KPa, the printing speed is 1-10 mm/s, the included angle between two adjacent printing layers formed by the printing lines with the core-shell structure is 30-90 degrees, the line interval is 20-2000 mu m, and the number of deposition layers is 2-10.
9. The modified tussah silk fibroin 3D printing bracket prepared by the preparation method of the modified tussah silk fibroin 3D printing bracket as claimed in any one of claims 1 to 8, is characterized in that: the printing line is composed of a printing line with a core-shell structure, wherein the core part of the printing line with the core-shell structure mainly consists of chemically modified tussah silk fibroin nano microfibers, and the shell part mainly consists of chemically modified tussah silk fibroin nano microfibers and gelatin.
10. The modified tussah silk fibroin 3D printing scaffold of claim 9, wherein the resolution of the modified tussah silk fibroin 3D printing scaffold is 0.5-10.0 μm.
CN201910773760.9A 2019-08-21 2019-08-21 A kind of modified tussah silk fibroin 3D printing scaffold and preparation method thereof Active CN110859994B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910773760.9A CN110859994B (en) 2019-08-21 2019-08-21 A kind of modified tussah silk fibroin 3D printing scaffold and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910773760.9A CN110859994B (en) 2019-08-21 2019-08-21 A kind of modified tussah silk fibroin 3D printing scaffold and preparation method thereof

Publications (2)

Publication Number Publication Date
CN110859994A CN110859994A (en) 2020-03-06
CN110859994B true CN110859994B (en) 2020-10-30

Family

ID=69652390

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910773760.9A Active CN110859994B (en) 2019-08-21 2019-08-21 A kind of modified tussah silk fibroin 3D printing scaffold and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110859994B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111454614B (en) * 2020-05-28 2022-05-24 苏州大学 3D biological printing ink and preparation method and application thereof
CN113274555B (en) * 2021-05-31 2022-05-03 清华大学 Artificial ventricle with bionic spiral orientation microstructure and preparation method thereof
WO2024216332A1 (en) * 2023-04-18 2024-10-24 Deakin University Wet particle emulsifier
CN116970304B (en) * 2023-06-13 2025-02-14 华南理工大学 A MnO2-protein fiber composite particle gel ink and its preparation and application

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102827376A (en) * 2012-09-10 2012-12-19 江苏科技大学 Preparation method of sulfated silk fibroin material
WO2016019078A1 (en) * 2014-07-30 2016-02-04 Tufts University Three dimensional printing of bio-ink compositions
CN107041971A (en) * 2016-09-19 2017-08-15 盐城工业职业技术学院 A kind of fibroin based on 3 D-printing/gelatin timbering material and preparation method thereof
CN107551321A (en) * 2017-09-22 2018-01-09 广州迈普再生医学科技有限公司 Organizational project Bone Defect Repari fiber and bone repairing support and preparation method thereof
WO2018089515A1 (en) * 2016-11-09 2018-05-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 3d vascularized human ocular tissue for cell therapy and drug discovery
CN108215165A (en) * 2018-01-25 2018-06-29 清华大学 Intelligent pattern of skin-core structure fiber and printing method and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102827376A (en) * 2012-09-10 2012-12-19 江苏科技大学 Preparation method of sulfated silk fibroin material
WO2016019078A1 (en) * 2014-07-30 2016-02-04 Tufts University Three dimensional printing of bio-ink compositions
CN107041971A (en) * 2016-09-19 2017-08-15 盐城工业职业技术学院 A kind of fibroin based on 3 D-printing/gelatin timbering material and preparation method thereof
WO2018089515A1 (en) * 2016-11-09 2018-05-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 3d vascularized human ocular tissue for cell therapy and drug discovery
CN107551321A (en) * 2017-09-22 2018-01-09 广州迈普再生医学科技有限公司 Organizational project Bone Defect Repari fiber and bone repairing support and preparation method thereof
CN108215165A (en) * 2018-01-25 2018-06-29 清华大学 Intelligent pattern of skin-core structure fiber and printing method and application thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
3D-printed scaffolds with synergistic effect of hollow-pipe structure and bioactive ions for vascularized bone regeneration;Wenjie Zhang 等;《biomaterials》;20170503;第135卷;第85-95页 *
A Gelatin-sulfonated Silk Composite Scaffold based on 3D Printing Technology Enhances Skin Regeneration by Stimulating Epidermal Growth and Dermal Neovascularization;Si Xiong 等;《scientific reports》;20170627;第7卷;第4288页 *
Bioprintable, cell-laden silk fibroin–gelatin hydrogel supporting multilineage differentiation of stem cells for fabrication of three-dimensional tissue constructs;Sanskrita Das 等;《Acta Biomaterialia》;20140919;第11卷;第233-246页 *
丝蛋白材料的三维打印;孙放;《现代丝绸科学与技术》;20181231;第33卷(第2期);第35-38页 *

Also Published As

Publication number Publication date
CN110859994A (en) 2020-03-06

Similar Documents

Publication Publication Date Title
CN110859994B (en) A kind of modified tussah silk fibroin 3D printing scaffold and preparation method thereof
Ma et al. Synthesis and characterization of injectable self-healing hydrogels based on oxidized alginate-hybrid-hydroxyapatite nanoparticles and carboxymethyl chitosan
CN106267370B (en) Silk fibroin/cellulose 3D printing ink
Zou et al. 3D printed gelatin scaffold with improved shape fidelity and cytocompatibility by using Antheraea pernyi silk fibroin nanofibers
CN113679888A (en) Photocuring forming composite hydrogel matrix precursor, preparation method thereof and stent with same
CN103877617B (en) Two cross-linked hydrogel of injectable fibroin protein-alginate and preparation method thereof and using method
Zhang et al. Solvent mediating the in situ self-assembly of polysaccharides for 3D printing biomimetic tissue scaffolds
Jiang et al. Preparation of cellulose nanofiber-reinforced gelatin hydrogel and optimization for 3d printing applications.
CN106479195A (en) A kind of nano-cellulose strengthens fibroin albumen composite material and preparation method thereof
CN114588312B (en) Functionalized fiber macromolecular cross-linked body bonded 3D printed elastic implant and its preparation method and application
CN115521627A (en) Structural protein/hyaluronic acid composite micro-nano particle, particle hydrogel material and application
CN101942709A (en) CS/PVA compound nanofibre containing multi-walled carbon nanotubes (MWNT) and preparation method thereof
CN113150561B (en) Collagen-based biological ink for 3D biological printing and preparation method and application thereof
CN111320767B (en) A preparation method of thixotropic hydrogel for 3D bioprinting
CN106492273B (en) A kind of dual enhancing Biodegradable polyester fibrous composite of chitin whisker/chitosan nano fiber and the preparation method and application thereof
WO2020134445A1 (en) Solution spray preparation method for scaffold for active biological tissue engineering
CN111097068A (en) Bionic hydroxyapatite powder/gelatin/sodium alginate composite 3D printing support and preparation method thereof
CN107537063B (en) A composite porous scaffold containing carbon nanotubes and its preparation method
CN104548200B (en) Method of preparing highly branched polysaccharide-fibroin hydrogel bracket
CN111471193A (en) Dialdehyde polysaccharide nanoparticle crosslinked collagen hydrogel and preparation method thereof
CN106798948A (en) A kind of method of regulation and control biofilm surface topological structure to promote cell to creep
Chen et al. Preparation of a novel regenerated silk fibroin-based hydrogel for extrusion bioprinting
CN111454614A (en) 3D bioprinting ink and its preparation method and application
Govorčin Bajsić et al. Preparation and characterization of electrospun PCL/silk fibroin scaffolds
CN115368744B (en) Preparation and application of a kind of silk protein and structural protein polymer composite nanoparticles

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant